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ABSTRACT
Pharmaceuticals and personal care products (PPCPs) are biologically active,
organic chemicals that are introduced into the environment through wastewater streams.
These chemicals are being found in the environment in trace concentrations and are of
concern due to their unknown potential for harm to the health and welfare of the
environment. The hypothesis is that during the course of wastewater treatment in a
municipal lagoon system from a small community, PPCPs are seeping into ground water
resulting in chronic low exposure in the environment. The objective of this work was to
study a specific wastewater lagoon treatment system in Mountain Home, Idaho and the
surrounding ground water for PPCPs. Water samples were taken from influent, lagoons,
and surrounding ground water wells to look for presence of PPCPs. A conceptual model
of the ground water flow was developed in order to link lagoon seepage to surrounding
ground water wells. The ground water flow model combined with the sampling data was
used to show that PPCPs are present in the lagoons and seeping into the ground water in
very low yet detectable concentrations. PPCPs were detected in the samples from the
headworks, in the storage lagoon, and in a monitoring well downgradient of the lagoon.
Twelve PPCPs were tested and eleven were found in the headworks in concentrations up
to 7,920 ng/L. Seven PPCPs were found in the storage lagoon in concentrations up to
880 ng/L. Six PPCPs were found in a downgradient monitoring well in concentrations up
to 82 ng/L.
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INTRODUCTION AND HYPOTHESIS
Pharmaceuticals and personal care products (PPCPs) are biologically active,
organic chemicals found in the environment at trace concentrations (Daughton 2004;
Kummerer 2004; Heberer 2002; Ternes and Joss 2006; EPA 2008; USGS 2002). Due to
their unknown potential for carcinogenicity, biological activity, and promotion of
antibiotic resistance in certain organisms, PPCPs are an emerging concern (Daughton
2004; EPA 2008; USGS 2002). PPCPs are introduced into wastewater streams through
household drains and subsequently enter municipal wastewater treatment systems (EPA
2008; Richards 1996; Bound and Voulvoulis 2005). Subsequently, wastewater enters the
environment through seepage from all types of treatment facilities or direct discharge of
treated water to the environment (EPA 2008; Kummerer 2004; Ternes and Joss 2006).
This transmission of water from household to treatment system to ground water
represents a major potential pathway for PPCPs to enter the environment (EPA 2008;
Dingman 2002; Domenico and Schwartz 1998; USGS 2008a).
While a number of studies have been performed on large municipal treatment
systems to understand the interactions of PPCPs with the environment, little work has
been performed to investigate the lagoon style wastewater treatment systems that are
prevalent throughout the United States (EPA 2002). It is possible that PPCPs are seeping
into ground water from the wastewater treatment lagoons or land application of treated
wastewater; however, studies to date linking PPCPs and lagoon seepage are limited
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(EPA 2007b). It has been hypothesized for this study that during the course of wastewater
treatment in a lagoon system and subsequent land application of the effluent, some
PPCPs are seeping into ground water in a form or concentration that can be detected
using currently available analytical techniques. In addition, wastewater treatment lagoons
and land application of wastewater form part of the exposure route of trace chemicals in
the environment. Grab samples of wastewater and area ground water in the vicinity of a
selected lagoon system have been collected and evaluated for both presence and trend
analysis of PPCP concentrations as they relate to the site-specific conditions. The results
will provide information about possible exposure routes of trace chemicals in the
environment from wastewater treatment lagoons.

Scope of Thesis
There are approximately 200 wastewater land application sites permitted by the
Department of Environmental Quality (DEQ) throughout the state of Idaho; these
wastewater reuse permits were examined to identify a suitable project site that used
facultative lagoons as the wastewater treatment process. Once identified, the site was
researched for historical information on wastewater treatment (flow, lagoon specification,
detention time, and land application), population base, and site geology (soils, vadose
zone, aquifer systems, ground water recharge, ground water flow direction, and existing
wells). The presence and concentrations of PPCPs are known to be influenced by
economic and demographic structure (Trapp and Matthies 1998) and thus were important
criteria in the site selection. Water samples were collected before and after wastewater
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treatment, as well as from ground water. Sample sites included a municipal wastewater
lagoon and water bodies downgradient from wastewater treatment. Samples were
analyzed for PPCPs and changes in PPCP concentration from influent to effluent to the
local ground water system and were evaluated to develop a conceptual model for fate and
transport of PPCPs. Oxygen and deuterium isotope data were used to determine linkages
between treatment system sources of the chemicals and the concentrations found in the
local and regional ground water. These data, along with concentration gradients, were
used to establish hydraulic connectivity between the wastewater lagoon seepage and
ground water. A qualitative analysis was performed, excluding a quantitative analysis of
the transport of the PPCPs from the lagoon due to the limited budget and to limit the
scope of research.

Background
Environmental Pathways for Pharmaceuticals and Personal Care Products
Trace chemicals that are biologically active in humans and other vertebrates are
found around the world in very low concentrations in ground water, rivers, lakes and
coastal waters (EPA 2008; Kummerer 2004; Ternes and Joss 2006). This thesis will focus
on a subset of these contaminants that includes both pharmaceuticals and personal care
products (PPCPs). As shown in Figure 1, PPCPs are introduced into wastewater streams
through household and hospital drains and subsequently enter municipal wastewater
treatment systems (Richards 1996; Metcalf and Eddy 1991; Bound and Voulvoulis 2005).
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Figure 1 Pathways for PPCPs (adapted from EPA 2008; Kummerer 2004;
USGS 2002; Ternes and Joss 2006; Garg and Jha 2005; Heberer 2002)
Many current wastewater treatment methodologies were not designed to remove
PPCPs (EPA 2007b; Heberer 2002; Gobel et al. 2007; EPA 2008). Some studies indicate
that secondary wastewater treatment processes (i.e., activated sludge and membrane
bioreactors) only partially remove PPCPs (EPA 2007b; Heberer 2002; Gobel et al. 2007;
EPA 2008). Studies indicate that post-treatment effluents from these processes contain
PPCPs (EPA 2008; USGS 2008b; Snyder et al. 2004). Information is more limited on the
fate and transport of PPCPs from facultative treatment lagoons. Because there are over
7,000 facultative lagoons in use in the United States located in less populated cities and
towns (EPA 2002), their design and use has led to wastewaters entering the environment
through seepage from the treatment facilities or direct discharge of treated water to the
environment (EPA 2008; USGS 2008b). The cycling of water from household to
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treatment system to ground water represents a major potential pathway for PPCPs to
enter the environment (Heatwole and McCray 2007; Garg and Jha 2005; Hai-long and
Zu-xin 2006; Connell and Van den Dael 2003; Marshall et al. Jaffe, 2000; USGS 2007).
However, limited information now exists on the fate of these chemicals in soils and
ground water from any treatment source, especially from wastewater lagoon systems
(EPA 2008; USGS 2008b). In order to explore the environmental fate and transport of
PPCPs, this study considered the topics of pharmacodynamics, wastewater treatment by
facultative lagoons, ground water hydrology, ground water chemistry and stable isotopes
for identification of respective PPCPs.
PPCPs enter wastewater in three primary ways. In urine and feces, humans
excrete small quantities of the pharmaceuticals they consume (EPA 2008; Drug
Information Online 2008). While the metabolism of pharmaceuticals varies by individual,
the principal means of elimination is generally through the urine stream (Hughes 1996;
Drug Information Online 2008; EPA 2008). Additionally, unused pharmaceuticals enter
wastewater when flushed into the sewer system, as has commonly been recommended as
a means of disposal (EPA 2008). Finally, personal care products, such as shampoo and
soap, enter wastewater when they are washed off any part of the body (EPA 2008). The
following section describes wastewater treatment processes involving municipal
wastewater lagoons and land application of treated wastewater, both of which are
possible sources of PPCPs to the environment.
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Wastewater Treatment
Facultative Lagoons
Wastewater treatment methods impact the amount of and potential for specific
PPCPs to be present in effluent (EPA 2008; Heberer 2002; Conn et al. 2006; Matamoros
et al. 2005). PPCPs are organic compounds and to date, limited data exist on the fate of
PPCPs in facultative lagoons (EPA 2008; EPA 2007b). The most important removal
pathways of organic compounds during wastewater treatment are:
biotransformation/biodegradation, adsorption by the sludge (excess sludge removal), and
stripping by aeration (volatilization) (Richards 1996; Metcalf and Eddy 1991; Qasim
1999). Lagoons have primarily been studied as a source for nitrogen loading to ground
water (DeSutter et al. 2005). Knowledge of how facultative lagoons work is fundamental
for understanding the potential fate of PPCPs in this thesis.
Facultative lagoons are ponds designed to hold and treat wastewater through a
combination of physical, biological (aerobic and anaerobic degradation reactions), and
chemical processes (Figure 2) (EPA 2002; Harris 2003). Each zone has the potential to
degrade organic compounds, including PPCPs. Lagoons can remove settleable solids,
biochemical oxygen demand, pathogens, fecal coliform, and ammonia (EPA 2002).
Lagoons are a treatment system relying on complex biochemistry to degrade organic
wastes present in wastewater as contained in an earthen berm constructed tank
environment (EPA 2002; Qasim 1999; Richards 1996; Metcalf and Eddy 1991).
Detention time allows solids to settle and aerobic, facultative and anaerobic zones are
created in the ponds (EPA 2002; Qasim 1999; Richards 1996; Metcalf and Eddy 1991).
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As Figure 2 shows, each of these zones is biologically and physically active and different
chemical processes treat the wastewater (Harris 2003).

Figure 2 Wastewater Treatment Zones in a Facultative Lagoon (adapted from
Metcalf and Eddy 1991; Harris 2003)
Lagoon systems are prevalent in use in the United States (EPA 2002), and there
are more than 400 lagoon treatment systems in Idaho according to the Idaho Rural Water
Association (2008). The simple design, operations, and low capital costs make them a
cost effective wastewater treatment method (Army Corps of Engineers; Muga and
Mihelcic 2008; Zhang 2001). Compared to mechanical wastewater treatment systems,
lagoon systems can cost four to five and a half times less (Muga and Mihelcic 2008),
which makes them a viable option for many communities, and socio-economic
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considerations. Lagoon systems also have the potential to contribute PPCPs to the
environment, making this current study of them timely and important.
Lagoons seep liquids, which percolate into the subsurface. This thesis considers
wastewater seepage from lagoons as a potential path for PPCPs to enter into the
environment. Lagoon seepage could provide a major source of PPCPs to enter into the
environment (see Figure 3).

Figure 3 Lagoon Seepage Into Ground Water (adapted from Dingman 2002;
Freeze and Cherry 1979)
The current Idaho Wastewater Rules (IDAPA 58.01.16.493) specify design
standards for a maximum seepage rate of five hundred gallons per acre per day for new
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lagoon construction. In contrast to the design standards, the rules also require seepage
testing to show that existing lagoons constructed after April 21, 2007 seep less than 0.125
inches (3400 gallons) per acre per day. Existing lagoons constructed before April 21,
2007 may seep up to 0.250 inches (6800 gallons) per acre per day. Lagoons must be
tested every ten years for seepage to ensure compliance with the rules. After evaluating
lagoon seepage testing reports from 2005 through 2008 (DEQ 2009), the results indicated
that all municipal lagoons tested to date seep to some extent. Lagoons may be designed to
have minimal seepage, but during the course of use operational and maintenance issues
(such as membrane punctures, weeds, slope stability, or cleaning) can create conditions
where seepage occurs or increases (Harris 2003). Nitrates and ammonia are two possible
drinking water contaminants that can seep from lagoons into ground water. The EPA has
set maximum contaminants levels (MCL) for nitrates and ammonia in drinking water,
which in turn limits how much of each parameter may seep from a lagoon. The EPA has
not, however, established MCLs for the PPCPs under consideration in this thesis, leaving
PPCPs currently unregulated (EPA 2008; Idaho Department of Administration 2008).
Wastewater Land Application
After lagoon treatment, wastewater effluent may still contain PPCPs and, if land
applied, could contribute additional PPCPs to ground water after percolating through the
soils. Applying wastewater to land is a way to naturally treat wastewater through soil
filtration, biological activity, and plant uptake of nutrients; provide aquifer recharge; and,
eliminate the need for wastewater discharge directly into a surface water body (DEQ
2007; Heatwole and McCray 2007). Land application of treated wastewater allows for
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water reuse, as it can provide a source of irrigation water and nutrients for crops (DEQ
2007; Coppola et al. 2004). A natural treatment system, wastewater land application is
generally constituent limited (i.e., hydraulics, nutrients, salts, etc) and considers
agronomic rates of nutrient uptake when crops are grown using the wastewater (DEQ
2007). Wastewater land application is managed to address where the water travels, its
surface residence time, its subsurface flow paths, water quality impacts to ground water,
and the amount of crop cover uptake for both water and its nutrients (DEQ 2007).
Wastewater land application with a crop system, as seen in Figure 4, is considered a
treatment system, not a disposal mechanism (DEQ 2007).

Figure 4

Potential Treatment of Wastewater from Land Surface to Ground
Water (adapted from DEQ 2007)
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Because land application of wastewater is a treatment system, the additional
treatment processes may be important when evaluating the PPCP contribution in the land
applied water. In addition to the typical wastewater processing in the soil layers, there are
potential PPCP-specific processing mechanisms that are shown in Figure 5.

Figure 5 Potential for PPCPs Treatment in Subsurface (adapted from
EPA 2008; Hai-long and Zu-xin 2006; Muller et al. 2007; Kummerer 2004)
The goal is to apply wastewater at a rate and manner that will allow the sitespecific crop system to assimilate the wastewater constituents such that minimal amounts
will leave the site through leaching or runoff (DEQ 2007). Wastewater land application
and treatment may be analogous to a controlled precipitation event because the goal is to
apply wastewater at a rate and manner for optimizing crop uptake of constituents
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(DEQ 2007). Wastewater land application is a seasonal land use system (DEQ 2007) that
relies on site-specific design and operation to prevent hydraulic overloading, ground
water contamination, and impacts to surface water (such as from runoff) at the
application site (DEQ 2007; Hai-long and Zu-xin 2006). Parameters currently monitored
at Idaho wastewater re-use sites are site- and system-specific for system design and
operation and include hydraulic and constituent loading (i.e., nitrogen, total dissolved
solids, phosphorus, and chemical oxygen demand) (DEQ 2007). The fate and transport of
PPCPs is not regulated and thus not monitored in wastewater treatment lagoons,
wastewater reuse sites, or subsequently in the receiving ground water (EPA 2008; Idaho
Department of Administration 2008). It is now being recognized that, after treatment,
wastewater still contains trace PPCPs that are biologically active (EPA 2008; USGS
2002; USGS 2008a; Drewes 2007; Snyder et al. 2004). The fate and transport of these
emerging contaminants involves a variety of complex processes, and further
understanding of the potential pathways is needed (EPA 2008; USGS 2002; USGS
2008a; Snyder et al. 2004).

Environmental Pathways and Fate of PPCPs in Wastewater
Throughout the wastewater treatment process, air, water, soil, and biota present
multiple potential pathways for PPCPs present in wastewater to enter the environment
(Metcalf and Eddy 1991; Qasim 1999; Richards 1996; Fetter 1999). Three factors
influence fate and transport of PPCPs: 1) the unique physiochemical properties of PPCPs,
2) the transport properties of the receiving environment (see Figure 2 and 3), and
3) chemical transformations of PPCPs along the transport process, which are important in
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interface dynamics (Domenico and Schwartz 1998; Kinney et al. 2006; Fetter 1999;
Crosby 1998). In the dynamic and variable environment that PPCPs encounter during
wastewater treatment, PPCPs partitioning coefficients may be important for predicting
what will occur during vapor/solid, vapor/liquid, liquid/liquid, or liquid/solid stages in
treatment and in the environment (Kummerer 2004; Fetter 1999; Crosby 1998). The
tendency of PPCPs to be in water versus sorbed can provide information about where it
might exist in the wastewater treatment system. The octanol-water distribution coefficient
(Kow) will “indicate the tendency of an organic chemical to partition to lipids or fats, sorb
to particulates such as soils, sorb to biomass or sludge or distribute among the various
environmental compartments” (Kummerer 2004; Fetter 1999). For example, sorption
affinity will be influenced by the molecule‟s Kow, its aqueous solubility and its molecular
structure (Kinney et al. 2006; Kummerer 2004). The less polar a chemical or PPCP is the
more potential for hydrophobic partitioning to organic matter to occur (Kinney et al.
2006). The greater the hydrophobicity of the chemical, the greater will be the tendency
for the PPCPs to partition into the hydrophobic organic phase (Kinney et al. 2006). The
greater the chemical‟s Kow, the greater will be the tendency for low water solubility, a
large soil/sediment adsorption coefficient, and a large retardation factor (Kinney et al.
2006; Lissemore et al. 2006; Kummerer 2004). A flow path relationship has been shown
to exist with PPCP concentrations (Lissemore et al. 2006). Past studies indicate that
water-soluble chemicals follow water flow paths and chemicals with high Kow values
tend to be found in soils with high total dissolved organic carbon (Lissemore et al. 2006).
These trends suggest that hydrophilic PPCPs may not attenuate during lagoon treatment.
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Therefore, understanding a PPCP‟s known chemistry with particular emphasis on Kow
will provide clues for defining pathways to degradation, sorption, or transport. A sorption
guide has been proposed (Drewes 2007; Rogers 1996) that refers to a chemical‟s octonal
water partitioning coefficient where a log Kow less than 2.5 will have low sorption
potential (Drewes 2007; Rogers 1996). A log Kow between 2.5 and 4 will have medium
sorption potential and a log Kow greater than 4 will have a high sorption potential
(Drewes 2007; Rogers 1996).
In evaluating wastewater treatment systems and PPCPs, the log Kow provides
predictive evidence for understanding the pathway a PPCP will take, i.e. water or soil
(sludge). For PPCPs in wastewater, it has been suggested that the concentration
difference between the influent and effluent provide the clearest indicator of total
removal efficiency when based upon a mass balance change (Aga 2008).

PPCP Pharmacodynamics
Understanding PPCP pharmacodynamics, the reactions between drugs and living
systems, is needed for proper evaluation of the sampling results. The chosen PPCPs were
designed to be biologically active chemicals that target end users, so that their direct
effects, which include their mode of action and side effects, are primarily understood
(Drug Information Online 2008). The chemistry of the chosen PPCPs is variable and little
is known about chronic low dose exposure, effects on non-target organisms, and/or
environmental fate and transport (Aga 2008; Drug Information Online 2008;
Crosby 1998; Jjemba 2008; Snyder et al. 2004). As a group, a homogeneous set of
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characteristics both in vivo and in the environment is not expected (Aga 2008; Drug
Information Online 2008; Crosby 1998; Jjemba 2008; Bateman 2001). Pharmaceutical
metabolism generally occurs in vivo and involves chemical changes that most often
convert PPCPs into more readily excreted polar products, thus making them water
soluble (Kummerer 2004; Jjemba 2008; Bateman 2001; Snyder et al. 2004). In general,
most drugs are lipophilic chemicals (Nowak 2005) and their metabolites become more
hydrophilic for elimination (Kummerer 2004; Drug Information Online 2008). This is an
important characteristic in the discussion on environmental fate and future study needs.
Another general point is that pharmaceuticals and their metabolites in addition to being
biologically active are often resistant to degradation. PPCPs may be excreted as the
original „parent‟ compound, as a conjugate, as metabolite(s) or a combination of the three
(Aga 2008; Crosby 1998; Kummerer 2004; EPA 2008; Jjemba 2008). The wastewater
collection system as discussed earlier, collects PPCPs as they are washed off of the body,
flushed down household drains, or passed out of the body through elimination. The target
PPCPs for this study are in Table 1 and the following discussion of carbamazepine,
gemfibrozil, sulfamethoxazole, and estrogens is needed for further understanding of this
study.

Table 1

PPCP Physiochemical Properties (adapted from Snyder et al. 2004)

PPCPs

Use

Caffeine
Carbamazepine
Esterone

Stimulant
Anti-seizure
Estrogen

Molecular
Weight
194.2
236.3
270.4

Log
[Kow]
-0.07
2.45
3.13
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PPCPs

Use

Estradiol
Ethinyl Estradiol 17 alpha
Gemfibrozil
Ibuprofen
Iopromide
Progestrone
Sulfamethoxazole
Testosterone
Trimethoprim

Estrogen
Synthetic Estrogen
Anti-cholesterol
Analgesic
X Ray Contrast
Estrogen
Anti-biotic
Androgen
Anti-biotic

Molecular
Weight
272.4
296.4
250.3
206.3
791.1
314.5
253.3
288.4
290.3

Log
[Kow]
4.01
3.67
4.77
3.97
-2.05
3.87
0.89
3.32
0.91

Carbamazepine
Carbamazepine, an anti-psychotic, anti-epileptic, anti-neuralgic, and anti-diuretic
drug (Drug Information Online 2008; RxList 2009), is one of the most frequently
detected PPCPs in surface waters and not naturally present in ground water (Clara et al.
2005; Miao et al. 2005; Metcalfe et al. 2004; Godfrey et al. 2007; Gagne et al. 2006).
Carbamazepine is a highly polar molecule, (Aga 2008; Daughton 2007; Drewes 2007; Jos
et al. 2003), about 3% is excreted unchanged in the urine (Daughton 2007; Drewes 2007;
Jos et al. 2003) and limited studies indicate that less than 10% is removed during sewage
treatment (Ternes et al. 2004; Hernando Guil et al. 2007; Miao et al. 2005).
Carbamazepine has been found in ground water with no degradation shown in travel
times of more than 6 years (Heberer 2002; Godfrey et al. 2007; Aga 2008;
Snyder et al. 2004). These characteristics have led to speculation that carbamazepine may
be considered as an ideal tracer and could serve as an indicator of wastewater seepage
(Clara et al. 2004; Haack et al. 2009). Ideal tracers are chemicals where there is no
sorption or reactions that will occur with it in the system of study (Dingman 2002; Trapp
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and Matthies 1998). Ideal tracers can be a chemical that is present at measureable levels,
and is not attenuated in the vadose zone or impacted by vegetation (Dingman 2002).
Sulfamethoxazole
Sulfamethoxazole is a sulfonamide-based drug. Sulfonamides are generally used
as antibacterial agents and are the most used class of antimicrobials in the world for
humans and livestock (Kummerer 2004; Metcalfe et al. 2004). Their mode of action is
through competitive inhibition of bacterial folate biosynthesis, which is needed for
nucleic acid synthesis and thus cellular division (Ternes and Joss 2006). This is a process
that may have important implications to biological (aerobic and anaerobic) degradation
reactions in facultative lagoons. The overall biodegradation in wastewater treatment may
be slowed down by antibiotics deactivating the microbial degraders. Since antibiotics are
included in the wastewater mixtures, there may be plant operation and treatment issues
that occur as a result of deactivating microbial degraders in treatment (Jjemba 2008). This
could be important to the discussion of the results if antibiotics are found in the lagoons.
Additionally, as antibiotic resistant bacteria can be found in wastewater (Volkman et al.
2004), the antibiotics found in wastewaters may have a potential role in the spread and
maintenance of multi-resistance of bacterial pathogens (Ternes and Joss 2006; Boreen et
al. 2004; Gobel et al. 2005).
Sulfonamides are generally metabolized by acetylation in humans and only about
15-20% of the active drug appears in the urine (Aga 2008; Ternes and Joss 2006; Gobel
et al. 2005). Sulfonamide residues are potentially carcinogenetic, and one form,
sulfamethazine, is a thyroid carcinogen (Metcalfe et al. 2004), necessitating the
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evaluation of concentrations in wastewaters as an important factor for risk assessment in
future studies. During wastewater treatment, there is potential for retransformation back
to the parent compound (Gobel et al. 2007; Gobel et al. 2005). Sulfonamide removal in
activated sludge and membrane bioreactor (MBR) treatment has been shown to be
variable but overall incomplete so that it is detectable in the effluent (Karthikeyan and
Meyer 2006; Gobel et al. 2007). Secondary treatment methods generally reduce
sulfonamides via sorption and transformation processes (Karthikeyan and Meyer 2006;
Gobel et al. 2007). Sulfamethoxazole is hydrophilic (refer to Table 1) and the mostly
commonly detected form in a study looking at sulfonamides (Gobel et al. 2005).
Sulfamethoxazole has been found in ground water samples (Focazio et al. 2004) and in
shallow ground water wells hydraulically downgradient from a community septic tank
drainfield (Godfrey et al. 2007). When considering its environmental fate in a lagoon, a
study on sulfamethoxazole showed that it may undergo slow photo-degradation in lakes
(Boreen et al. 2004).
Gemfibrozil
Gemfibrozil is an antihyperlipidemic drug that reduces triglycerides and increases
cholesterol carried in high density lipoprotein (Drug Information Online 2008).
Gemfibrozil forms metabolites that are eliminated in urine and feces. Six percent of the
dose can be accounted for in the feces and approximately seventy percent of the
administered human dose is excreted in the urine, with less than 2% excreted as the
unchanged parent compound (Drug Information Online 2008). Gemfibrozil has a high
hydrophobicity (refer to Table 1) and with this tendency to partition into the hydrophobic
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organic phase, it has also been found in treated effluent from wastewater systems with
removal efficiencies ranging from 6 to 50% (Quinn et al. 2008; Gagne et al. 2006;
Daughten and Ternes 1999). Studies also suggest it may be one of the ten most abundant
PPCPs found in wastewater effluent (Gagne et al. 2006). Studies with gemfibrozil
indicate a concern for embryonic effects in mammals and that its toxicity rating should be
reclassified (Quinn et al. 2008). This makes its environmental presence important for
evaluation.
Estrogens
Estrogens occur in males and females during their entire lifetime and have
different biological effects on the different target tissues (EPA 2008; Raftogianis et al.
2000; Okayasu et al. 2005). In addition to reproductive organs, estrogens act on the brain,
bone, liver, and heart (Raftogianis et al. 2000; Okayasu et al. 2005). Estrogens are
eliminated from the body by conjugation whereby a hydrophilic side chain is attached
(glucuronic acid or sulfate) making it more soluble to enter the urine stream (Raftogianis
et al. 2000; Okayasu et al. 2005; Johnson and Williams 2004). Studies suggest that
de-conjugation can occur through enzymatic hydrolysis in the wastewater collection
system or treatment process (Drewes 2007; Snyder et al. 2004; Okayasu et al. 2005;
Johnson and Williams 2004). It is suggested that estrogens have high potential to be
adsorbed to sewage sludges and that longer solids retention times may result in better
removal efficiency of estrogens (Drewes 2007). This may be important at the study site
with a 22 day detention time traveling through the lagoons and an even longer detention
in the storage lagoon. It has been shown that there is a 60 to 90% removal efficiently of
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estrogens from wastewater using MBRs and conventional activated sludge wastewater
treatment methods (Hernando Guil et al. 2007). The bioavailability of estrogens to
influence the environment makes estrogens an important choice for evaluation in
wastewaters (Aga 2008; Clara et al. 2005; Conn et al. 2006; Drewes 2007; Snyder et al.
2004; Daughten and Ternes 1999; Jos et al. 2003; Daughton 2007; Gagne et al. 2006).
Nitrogen
Nitrogen is often used as an indicator for fecal contamination of ground water and
is being studied to determine if there is a correlation between monitoring parameters and
PPCPs (Jjemba 2008; Haack et al. 2009). As such, there may be a correlation between
PPCPs and nitrogen transport through the vadose zone and into ground water. Many
studies have shown that nitrogen transport from surface water sources into ground water
occurs (EPA 2008; Heatwole and McCray 2007; Garg and Jha 2005; DeSutter et al.
2005; Haack et al. 2009). Elevated nitrogen concentrations in ground water have been
implicated with wastewater treatment systems and agricultural operations (Heatwole and
McCray 2007; Garg and Jha 2005) and shallow aquifers may be vulnerable to nitrate
contamination (Garg and Jha 2005). Nitrogen removal from this wastewater treatment
lagoon system may also correlate with some of the chosen PPCPs. If nitrogen is found in
the ground water with PPCPs, the total removal efficiency of the PPCPs and nitrogen at
each sampling location can be evaluated.
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Oxygen and Deuterium Isotopes
Isotopes of oxygen and deuterium, a hydrogen isotope, have been shown to
provide a line of evidence toward establishing hydraulic connectivity, between surface
water and ground water (Domenico and Schwartz 1998; Freeze and Cherry 1979;
SAHRA 2005). The fractionation of the stable isotopes of oxygen (18O) and deuterium
(2H) in atmospheric water vapor is subject to changes when water evaporates and
condenses (Domenico and Schwartz 1998; Freeze and Cherry 1979; SAHRA 2005). A
linear correlation can be inferred as it relates to water that has not undergone evaporation
(Domenico and Schwartz 1998; Freeze and Cherry 1979; SAHRA 2005). Therefore,
water with different evaporative histories can have unique isotopic fingerprints
(Domenico and Schwartz 1998; Freeze and Cherry 1979; SAHRA 2005). Oxygen and
deuterium ratios can be plotted and compared to the Meteoric Water Line (MWL) (see
Figure 6), which is the annual average isotope composition of precipitation at locations
around the globe (Domenico and Schwartz 1998; Freeze and Cherry 1979; SAHRA
2005). The relationship between 18O and 2H in meteoric waters is as follows:
δ2H = 8 δ18O +10‰ (SAHRA 2005).
Water that has been unaffected by physio-chemical processes (evaporation)
should fall on the MWL line as it should contain more of the lighter oxygen, as seen in
Figure 6 (Domenico and Schwartz 1998; Freeze and Cherry 1979; SAHRA 2005).
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Figure 6

Summary of How Hydrological Processes Affect Oxygen and
Hydrogen Isotopic Composition of Water (SAHRA 2005)

As water becomes more depleted in the lighter isotopes through evaporation, it
will deviate from the MWL (Domenico and Schwartz 1998; Freeze and Cherry 1979;
SAHRA 2005). The greater the evaporation the farther away the sample will be from the
MWL (Domenico and Schwartz 1998; Freeze and Cherry 1979; SAHRA 2005). The
same or similar isotopic signatures suggest hydraulic connectivity between surface water
sources and ground waters (SAHRA 2005; Coplen et al. 2000). In this study, oxygen and
deuterium isotope ratios are used to provide evidence to evaluate the connectivity of
lagoon effluent seepage to ground water (SAHRA 2005; Coplen et al. 2000), because
wastewater is subject to evaporative processes during its travel time through a lagoon
(Metcalf and Eddy 1991). The same or similar isotopic signature found in lagoon effluent
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and ground water may suggest that the effluent, which may contain PPCPs, is recharging
ground water.

Study Location
In order to provide a basis for understanding PPCP contamination contributions
from wastewater to ground water, a study location was needed that could be searched for
pharmaceuticals in the environment, and assessed for hydrology with respect to
movement of pharmaceuticals to the ground water. A specific study site was chosen from
the Idaho Wastewater Reuse permitted sites list. The chosen study location was the City
of Mountain Home Idaho due to its wastewater lagoons, existing monitoring wells and
permitted wastewater land application site. The City of Mountain Home is located in
Elmore County, in southwestern Idaho (Figure 7).
The city had a population of 11,143 according to the 2000 census. The population
has grown to more than 12,500 according to the 2004 estimated census. The 2000 census
indicated that the population base is distributed in age with 29.6% under the age of 18,
9.8% between the age of 18-24, 32.8% between the age of 25-44, 18.1% between the age
of 45-64, and 9.7% over the age of 65. The median age was 32 years (Mountain Home
Economic Development 2004). This residential population contributes the PPCP loading
to the wastewater stream.
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Figure 7 Mountain Home Study Area Showing City of Mountain Home, and
Wastewater Treatment Facility and Extent of Irrigated Agricultural Area East of
Wastewater Treatment Facility (adapted from Baldwin et al. 2009)
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City of Mountain Home Wastewater Treatment
The wastewater treatment facility is located approximately 2 miles south of the
city in Elmore County, in sections 1, 2, 11 and 12, Township 4S Range 6E (Keller
Associates 2006). The location is north of Hamilton Road and is shown in Figure 8. The
general area land use is open range and agricultural fields, with some rural residential
surrounding the municipal wastewater treatment site. The site has been permitted by the
state since 1989 (Idaho DEQ Land Application Permit LA-000037) to land apply its
treated wastewater (DEQ 1996). The waste streams currently collected are from the
primarily residential population base; businesses do not contribute any known unusual
waste and there are no significant industrial discharges to the treatment system (DEQ
1996). Wastewater treatment consists of a nine cell facultative lagoon system (see Figure
9) that operates in series.
The wastewater treatment system was designed for an average daily flow of 1.71
MGD and a peak hourly flow of 4.9 MGD (DEQ 1996). The lagoons overall occupy 205
acres with a total volume when full of approximately 406 million gallons (DEQ 1996;
Keller Associates 2006). The first six clay lined lagoons are treatment lagoons with a
22 day detention time through the system (Keller Associates 2006; DEQ 2009).The last
three lagoons store the treated wastewater for up to 214 days during the winter months
(Keller Associates 2006; DEQ 2009). Storage lagoons seven (7) and eight (8) are clay
lined on the bottom with membrane liner on the sides and storage lagoon nine (9) is fully
membrane lined (DEQ 1998; Keller Associates 2006). Storage is followed by disinfection
using a chlorine solution directly injected into the pipe through a diffuser; treated effluent
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is then sent to be land applied on 260 acres during the growing season of April 1 through
October 31 (DEQ 1996; Keller Associates 2006). Irrigation pumps apply effluent by
sprinkler in accordance with Irrigation Water Requirements throughout the growing
season to fields that historically were planted with small grain, alfalfa, and sugar beets
(DEQ 2009; Keller Associates 2006). The permit requires that constituent loading to the
site for COD is limited to 50 pounds/acre-day for the growing season and the maximum
nitrogen loading is 150% of crop uptake.
In 2005, approximately 500 MG of wastewater entered the treatment system and
286 MG were land applied (Keller Associates 2006). The system was designed for lagoon
seepage to occur (Keller Associates 2006) and during this study seepage was estimated to
be 200 million gallons per year (Keller Associates 2006; DEQ 2009). Only eight lagoons
were in operation during sampling as lagoon six was taken offline in 2002 due to lagoon
seepage in excess of the state rule limit of 0.250 inches (6800 gallons) per acre per day
(DEQ 1998).
The wastewater treatment site has five monitoring wells (MW) and is shown in
Figure 10. The wells were all drilled to depths of less than 20 feet where basalt rock was
encountered (Keller Associates 2006; Mountain Home 1991). MW 1, MW 4, and MW 5
have all been dry as they have never encountered ground water (Mountain Home 1991).
MW 1 is 20 feet below the ground surface, MW 4 is 12.5 feet below the ground surface,
and MW 5 is 10.5 below the ground surface (Mountain Home 1991). MW 2 and MW 3
both have had water present since being drilled, MW 2 is 14 feet deep and MW 3 is 12
feet deep (Mountain Home 1991). The Mountain Home Land Application site
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Engineering Reports on file with DEQ and potentiometric contours maps of the regional
and perched water table show a south to southwesterly direction of ground water flow
(Figure 11 and 12) (Keller Associates 2006; Arney et al. 1984; Bendixsen 1994; Shervais
et al. 2002; DEQ 2009; Young et al. 1992). The contours support that MW 1 is
upgradient from the lagoons; MW 2 and MW 3 are downgradient from the lagoons and
upgradient of MW 4 and MW 5 (Figure 10).
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Figure 8 Mountain Home South Study Area with Township, Range and Section
Overlay Showing City of Mountain Home Wastewater Treatment Lagoons (adapted
from Baldwin et al. 2009)
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Figure 9 City of Mountain Home Wastewater Treatment Facility Lagoons
(adapted from Google Earth 2007)
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Figure 10 Monitoring Wells at Mountain Home Wastewater Treatment Facility
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Figure 11 Potentiometric Contours on the Regional Water Table, Mountain
Home Area (adapted from Young et al. 1992); Black Outline Shows General
Location of Mountain Home Wastewater Treatment Facility (adapted from Baldwin
et al. 2009)
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Figure 12 Potentiometric Contours on the Perched Water Table, Mountain
Home Area (adapted from Young et al. 1992); Black Outline Shows General
Location of Mountain Home Wastewater Treatment Facility (adapted from Baldwin
et al. 2009)
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Geology
The City of Mountain Home and the wastewater treatment site are on a southwest
sloping broad flat plateau that lies at an elevation of about 3,140 feet above mean sea
level on the northeast margin of the western Snake River Plain as shown in Figure 13
(Shervais et al. 2002; Arney et al. 1984).

Figure 13 Regional Map of the Western Snake River Plain Showing Mountain
Home, the Danskin Mountains to the North and the Mount Bennett Hills to the
Northeast (original source Shervais et al. 2002 and adaption taken from Baldwin et
al. 2009)
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The geological framework of the area provides a context for recharge to the local
and regional aquifer system (Baldwin et al. 2009). Rhyolite lavas from volcanic activity
form the base layer on which sediments and basalts were deposited (Shervais et al. 2002)
(Figure 14).

Figure 14 Interpretative Cross Section Across the Western Snake River Plain in
the Vicinity of Mountain Home; Line of Section A-A’ is Shown on Figure 13
(original source Shervais t al. 2002 and adaption taken from Baldwin et al. 2009)
Shield volcanoes located southwest of Mountain home created a basalt cap over
underlying sediments (Shervais et al. 2002; Wood and Clemens 2002). This basalt cap,
represented by QTrs on Figure 15, surrounds a topographic low that includes the City of
Mountain Home and the wastewater treatment site (Baldwin et al. 2009).
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Figure 15 Geologic Map and Explanation of Units for the Mountain Home Area
Prepared by Shervais et al. 2002 (original source Shervais et al. 2002 and adaption
taken from Baldwin et al. 2009)
Well drillers logs from wells located south of Mountain Home show that the
uppermost basalt is from about 460 to 540 feet thick and is overlain by deposits of clay,
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silt, sand and gravel, referred to as Quaternary Alluvium (Qal) on the map (Baldwin et al.
2009). The thickness of the alluvium (ranging up to about 80 feet) reveals the relief of the
underlying basalt surface (Baldwin et al. 2009) and was determined from drillers‟ logs for
wells located within the outline of the alluvial deposits as shown in Figure 16 (Baldwin et
al. 2009).
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Figure 16 Map Showing Outline of Qal in the Mountain Home Area and
Alluvium Thickness, in Feet, from Selected Wells (original source Shervais et al.
2002 and adaption taken from Baldwin et al. 2009)
This area forms the moat where the perched aquifer exists surrounded by basalt
(Shervais et al. 2002; Baldwin et al. 2009). A cross-sectional area of the Qal formation in
Figure 17 shows alluvial material that lies over the basalt.
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Figure 17 Cross Sectional Area of Study Site (derived from Baldwin et al. 2009)
Ground water
A shallow perched aquifer and a deep regional aquifer exist in this study area
(Norton et al. 1982; Bendixsen 1994; Baldwin et al. 2009). The localized perched aquifer
is within the shallow alluvial material mentioned above with the potentiometric contours
previously shown in Figure 12. This area underlies about 38,000 acres (Young et al.
1992) that includes the wastewater treatment site area. This aquifer has a depth to ground
water of 2 to 40 feet within the shallow sediments and is found mainly in the clay, silt,
sand, and gravel of the Quaternary Alluvium (Qal) (Norton et al. 1982). Recharge to the
perched aquifer occurs from local creeks, irrigation canals, and a reservoir located north
of the study area (Norton et al. 1982; Bendixsen 1994; Baldwin et al. 2009). Seepage
from the wastewater treatment lagoons also provides some recharge to the perched
aquifer (Norton et al. 1982; Bendixsen 1994). Ground water contour maps from multiple
studies of the area between 1968 and 1990 indicate that the direction of ground water
movement in the perched aquifer is towards the southwest (Norton et al. 1982; Keller
Associates 2006; DEQ 2009; Bendixsen 1994; Young et al. 1992), which includes the
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area at the wastewater treatment site as seen in Figure 12. An evaluation of data sets and
elevation contours for this perched aquifer from studies from 1968 to 1990 indicates that
no significant changes to flow direction or gradient have occurred over this time
(Bendixsen 1994). It is assumed that the sources of recharge water and the discharge area
remain similar to the conditions from 1968 to 1990. This area according to IDWR was
targeted for further hydrological study and due to budget constraints action toward the
study is on hold.
Depth to ground water in the deeper regional aquifer is from 200 to 400 feet
below land surface. The water is found primarily in basalts and poorly consolidated
detrital material (Norton et al. 1982; Bendixsen 1994; Baldwin et al. 2009; Young et al.
1992). The regional aquifer has permeable zones of highly fractured basalt that occur
within dense, relatively impermeable flow units. Recharge to the regional aquifer occurs
through precipitation in the mountains north of Mountain Home, percolation from
ephemeral streams on the plateau, and through percolation from the perched aquifer
(Norton et al. 1982; Bendixsen 1994). Ground water flow in the regional aquifer is in a
south to southwest direction (Norton et al. 1982; Keller Associates 2006) as shown in
Figure 11.

Conceptual Model
In order to evaluate the potential migration of the wastewater into the perched
aquifer a conceptual model of the underlying ground water flow regime is necessary. The
geological formations in the study area provide a context for discussion of the
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hydrogeologic conditions present at this site and are needed to develop a qualitative
conceptual model of ground water flow paths. Further, several historic studies of ground
water flow within the area are discussed.
Model Boundaries
The hydrogeologic conditions of the site combined with several dry wells around
the periphery of the perched aquifer establish boundary conditions where ground water is
not present. As a consequence, boundary conditions can be clearly defined to establish
ground water flow paths within the perched aquifer on a qualitative basis. A one box
model as outlined in Figure 18 was chosen, as there is not enough available quantitative
information to apply an analytical solution for contaminant transport (such as the
Domenico and Schwartz model) (Schnoor 1996). The goal of the conceptual model is to
describe in some qualitative manner flow characteristics and associated ground water
flow paths in the perched aquifer.
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Figure 18 Aerial View of One Box Model of Site System Boundary
The boundaries of the model have been chosen to correspond with known
boundary conditions where possible. Water flow in and out of the model boundaries is
used to characterize flow within the one box model. A three-dimensional box of the
boundaries is shown in Figure 19.
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Figure 19 Perspective View of Site System
The boundaries are described below.
Northerly No Flux Boundary
The northerly no flux boundary is a flow line that is dictated by the Potentiometric
Contours on the Perched Water Table, Mountain Home Area (Figure 12). The northerly
no flux boundary is a physical boundary associated with flow paths and extends through
Monitoring Well 1 where no ground water is present and follows the south west flow
path of the perched aquifer to the extent of the perched aquifer (Figure 18 and 19). This
boundary extends vertically from the ground surface approximately 20 feet to the basalt
cap. Dry wells, which extend to the basalt layer underlying the perched aquifer, lie along
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this boundary. As a consequence, it is assumed that no ground water flows across this
boundary.
Southerly No Flux Boundary
The southerly no flux boundary is a flow line that is dictated by the
Potentiometric Contours on the Perched Water Table, Mountain Home Area (Figure 12).
The southerly no flux boundary is a physical boundary associated with flow paths and
extends through Monitoring Well 4 (Figure 10), where no ground water is present and
follows the south west flow path of the perched aquifer to the extent of the perched
aquifer (Figure 18 and 19). This boundary extends vertically approximately 10 feet from
the ground surface to the basalt cap. As a consequence, no ground water flows in the
alluvium of the perched aquifer across this boundary.
Up gradient In-Flux Boundary
The eastern boundary extends horizontally from the eastern edge of the northern
boundary to the eastern edge of the southern boundary (Figure 19). Based upon the large
scale ground water gradients, of approximately 60 ft per mile (Young et al. 1992), ground
water flows into the perched aquifer of the conceptual model along this boundary.
Downgradient Boundary
The downgradient boundary (Figure 18 and19) exists to the western edge of the
alluvial deposits and thus the western extent of the perched aquifer (Shervais et al. 2002;
Baldwin et al. 2009). It extends horizontally from the western edge of the northern no
flux boundary to the western edge of the southern no flux boundary. This downgradient
boundary extends from the ground surface to the basalt cap. As a consequence of the
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alluvium material deposition ending, there is no ground water present as the alluvium of
the perched aquifer does not exist along this boundary. It is assumed that no flow exists
across this boundary.
Lower Boundary
The lower boundary is defined by the basalt cap underlying the perched aquifer
(Figure 20). At the western edge of this boundary, the basalt cap rises to the surface and
the alluvial sediment ends (Shervais et al. 2002; Baldwin et al. 2009). Based on this
information, it is assumed that flows through this boundary, if present, are downward
under the influence of gravity since it is not under confining conditions.
Upper Boundary
The upper boundary is defined by the ground surface as shown in Figure 20.
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Figure 20 Flow Paths Through System
Excluding wells, water crossing this boundary is from evaporation, precipitation,
lagoon seepage, and land applied wastewater. As discussed earlier, the 205 acres of
lagoons seep approximately 200 million gallons per year into the alluvium of the perched
aquifer. This represents a defined inflow into the conceptual model.
Flow Paths
The flow paths across the boundaries of the conceptual model characterize the
flow paths for water and PPCPs (Figure 20). Water flowing into the system could be from
precipitation, the upgradient perched aquifer, and the headworks. Water flowing out with
PPCPs could go to the downgradient perched aquifer (through the sludge of the lagoon),
be applied on the land application site, and flow from the perched aquifer into the basalt
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layer. Based upon the descriptions of the boundary conditions that are defined in the
conceptual model, MW 2 exists within the perched aquifer downgradient of seepage from
the lagoons. Based upon the descriptions of the boundary conditions that are defined in
the conceptual model, MW 3 is not downgradient of the lagoons. The conceptual model
and flow paths indicate that MW 2 has the potential to be impacted by PPCPs from the
lagoon if PPCPs exist in the perched aquifer. The conceptual model and flow paths
indicate that MW 3 exists in the perched aquifer but should not be impacted by any
PPCPs originating from the lagoons.

47

MATERIALS AND METHODS
In this section, the general approach to determine if PPCPs can be contributed to
ground water at the City of Mountain Home Municipal Wastewater Lagoon Treatment
site will be discussed. This provides a basis for understanding PPCP contamination
contributions from wastewater to ground water at the study site.
Local studies on the issue of PPCPs must focus on reconnaissance, which
includes collection of baseline data examining PPCP use patterns and related population
densities (Focazio et al. 2004). As studies of specific wastewater sites grow, the data may
expose relevant trends in PPCP fate and transport over the range of wastewater treatment
and hydrologic conditions across the United States. Concentration differences of PPCPs
found at this study site in the influent (the headworks) and the effluent (storage lagoon)
were evaluated for total removal efficiency. Additionally, concentration differences of
PPCPs found in ground water at monitoring wells at this study site were evaluated for
total removal efficiency.

Sampling Parameters
The sampling parameters will be discussed, followed by the sampling methods.
The target PPCPs for this study are in Table 1 and were chosen based upon analytical
capabilities, costs, occurrence data from previous studies (Aga 2008; Clara et al. 2005;
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Conn et al. 2006; Drewes 2007; Snyder et al. 2004; Daughten and Ternes 1999; Jos et al.
2003; Daughton 2007), and physio-chemical properties.
The target list includes primarily pharmaceuticals and was initially limited to
evaluating carbamazepine, gemfibrozil, sulfamethoxazole, and the estrogens
Progesterone, Esterone, Estradiol, and Ethinyl Estradiol 17alpha. Upon evaluation of
analytical laboratories capable of testing for these parameters, the list was expanded to
include twelve that were part of an analytical panel offered by the chosen lab. The
remaining PPCPs were only evaluated for presence or absence in analytical results.
Carbamazepine
Carbamazepine was reviewed to determine its flow through the system and
potential as an indicator PPCP. It is unknown if the demographics of the area around the
Mountain Home site are such that carbamazepine is used enough to be detectable in the
headworks; however, it was chosen due its detection in other studies and low octanolwater partitioning coefficient.
Sulfamethoxazole
Because studies have shown that sulfamethoxazole may be degraded in lakes, it
may be correlated to the storage lagoon water at this site. Based upon the limited
analytical data and the variance of fate and transport data, it was unknown if
sulfamethoxazole could be found in the treatment system or the ground water system in
the study area. The prevalence of its use worldwide suggested that it could be found in
the headworks if there was enough used in this community.
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Gemfibrozil
Since gemfibrozil has a high hydrophobicity and is found frequently in
wastewater effluent, it was chosen as a sampling parameter. It is unknown if gemfibrozil
will be detectable from this small population in the headworks. If it is present in the
headworks, the high hydrophobicity suggests that it may just go directly into the sludge.
Estrogens
Based upon the incomplete removal efficiency of estrogens reported, there is the
potential to find estrogens in the headworks and discharge effluent at this site. Four
estrogens were tested for in the samples; Progesterone, Esterone, Estradiol, and Ethinyl
Estradiol 17alpha (refer to Table 1). Each has a hydrophobicity, which influences a
tendency to partition into the hydrophobic organic phase, which suggests presence in the
sludge.
Isotopes in Wastewater Treatment Lagoons
The wastewater lagoon treatment is subject to evaporative processes during the
time it takes for water to travel through the series of nine lagoons, and as it remains in the
ponds for winter storage. Ground water within the site boundary impacted by the lagoons
should contain water with a similar isotopic signature as the lagoons, or be representative
of water that was mixed with evaporative water from the lagoons (Baldwin and Cook
2004; Baldwin et al. 2009). The oxygen and deuterium isotope results may provide
evidence for hydraulic connectivity between surface and ground water based on
evaporation (Crosby 1998; Baldwin and Cook 2004; Schnoor 1996; Baldwin et al. 2009).
It is expected that the ground water in the regional aquifer would not have been exposed
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to evaporative processes and that the headworks for the wastewater treatment system
water would have an isotopic signature similar to the regional aquifer since the regional
aquifer is the source of water to the city and thus to the wastewater treatment collection
system (Baldwin et al. 2009). It is also expected that if water from the lagoons
contributes to the perched aquifer, the perched aquifer should have an isotopic signature
similar to lagoon water (Baldwin and Cook 2004; Baldwin et al. 2009). A public water
system (PWS) well upgradient of the lagoon system was sampled. Water from this well
should be similar in isotopic signature to the water in the headworks since evaporative
processes are limited as water travels from the well to the wastewater treatment site.

Sampling Methods
Based upon expectation of flow paths (Figure 20), four sampling locations were
chosen to be sampled in series from the site that is assumed to have the least potential of
PPCPs to the site that had the greatest potential for high concentrations of PPCPs. Grab
water samples were taken November 2007, following the experimental plan as follows.
Samples were taken from Monitoring Well 2, then Monitoring Well 3. Afterward,
samples of wastewater were collected from the last wastewater lagoon in series and then
near the headworks or influent to the first lagoon.
All personnel on the water sampling team reviewed procedures for using EPA
Method 1669 (i.e., “clean hands/dirty hands” procedures) for Sampling Ambient Water
for Trace Metals. This protocol was modified for sampling trace PPCPs with appropriate
considerations for the ability to contaminant water samples with the PPCPs of interest.
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The intent is to maximize the ability of the field sampling team to collect samples reliably
and eliminate sample contamination. The collection of samples included a duplicate and
field blank for the first four samples taken. The duplicate consisted of sample containers
filled with the same composite water from the same sampling site. The duplicates
determine both field and laboratory precision. The field blank sample was used to
determine the integrity of the field sampling events, the condition of the sample
containers supplied by the laboratory, and the accuracy of the laboratory methods. Both
the duplicates and blank samples are stored and handled with the normal sample load for
shipment to the laboratory. MWH Laboratories (Table 2) was used for PPCP sample
testing as it met the Unregulated Contaminant Monitoring Regulations (UCMR)
Laboratory Approval Program application and Proficiency Testing (PT) criteria. MWH
Laboratories is an EPA Approved laboratory for sampling UCMR using EPA 527, 529,
521, 525.2, and 535 methods for PPCP analysis.

Table 2

Laboratories

Laboratory List

Parameters

Address

Idaho Bureau of
Laboratories

TKN, NH4, NO3-N, Cl,
SO4, TDS, Total P

2220 Old Penitentiary Rd
Boise ID 83712

U of Arizona
Environmental Isotope
Laboratory

Isotopes: 18O, D, 15N

Dept. of Geosciences
Tucson, AZ 852721-0077

MWH Laboratories

PPCPs

750 Royal Oaks Dr, Ste
100, Monrovia, CA
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The laboratory used for testing of general field parameters is the Idaho Bureau of
Laboratories (Table 2), which is certified for the chemical and microbiological testing of
drinking water from public water systems as part of the primacy agreement between the
State of Idaho and EPA. It is certified for microbiological, organic chemistry, and
inorganic chemistry analytes and methods.
The laboratory used for isotopes was the University of Arizona Environmental
Isotope Laboratory (Table 2). This laboratory has been used for isotope testing previously
for some of the sample sites and was used for consistency of sample and data evaluation.
At each well, a Geopump Peristaltic Pump was used to draw samples from the
wells. Field parameters for specific conductance, pH, temperature, and total dissolved
solids were measured with a Horiba Water Quality Checker U-10. The pH and
conductivity meters were calibrated to manufacturer specifications, then measurements
taken from each well while purging. Field parameter measurements were considered
stable when three successive measurements taken at intervals of 5 minutes or more
differed by the following: specific conductance 5% or less, pH 0.1 unit or less, and
temperature 0.2 ºC or less.
Prior to donning personal protective equipment and obtaining any sample, field
personnel designated roles and responsibilities for the sampling and discussed the
modified procedures that needed to be used during sampling events. Care was taken not
to spill any contaminants (e.g., water, etc.) on or near the sampling site, or to let any
sampling equipment come into contact with potential contaminants. Field personnel wore
powder-less nitrile laboratory gloves during sampling and processing and changed to
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clean gloves with each change in activity or potential glove contamination. They avoided
breathing directly over open samples/equipment and avoided direct contact between
themselves (including clothing) and the sample, sampling device, and processing
equipment. On the day of sampling activities, they avoided contact with or consumption
of the products listed below:


Wastewater compounds such as soaps and detergents, including antibacterial
cleansers.



Pharmaceutical compounds such as prescription drugs, medications, and
hormonal substances that are in the list of PPCPs.

Upon arrival at the sampling sites, one member of the two person sampling team was
designated as “dirty hands” and the other “clean hands.” The persons assumed the “dirty
hands” and “clean hands” roles wearing Tyvek coveralls and powder-less nitrile
laboratory gloves, and surgical masks with sampling equipment and containers
appropriately staged nearby. The dirty hands sampler observed techniques employed by
clean hands personnel and to notify the field team immediately in the event that any
possible contamination was observed or suspected, or if incorrect sampling techniques
were utilized.
The clean hands sampler touched the sample container and transferred the sample
from the sample collection device to the sample container. The dirty hands sampler was
responsible for the operation of the machinery and other activities that did not involve
direct contact with the sample. “Clean hands” placed the clean empty sample containers,
removed the lids of the containers, and placed the end of the tubing into the containers.
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“Dirty hands” started the pump. “Clean hands” moved the tubing to a clean container.
“Dirty hands” stopped the pump. “Clean hands” replaced the lid on the container and
returned the container to the designated place. “Dirty hands” placed the bottle into the
cooler. Gloves were changed between samples and sample sites. Samples were collected
as quickly as is reasonably possible, while carefully preventing any contact between the
containers and any surface other than the sampling surface. Lagoon samples were
collected by using a grab sampling technique, through immersion into the water by a
certified clean amber glass bottle and transferring that into the laboratory prepared
bottles. The water in the monitoring well samples was pumped to the surface and the
sample containers filled directly. Collected samples were stored in ice chests with freezer
packs to maintain 4oC from the time of the sampling event until sample custody was
transferred to the lab. After leaving the field, samples going to MWH laboratory were
packed for shipment and sealed in ice chests with refrigerated packs, with the required
chain of custody forms. Samples going to Idaho Bureau of Laboratories were dropped off
by field personnel and samples going to U of Arizona Environmental Isotope Laboratory
were shipped.
Some additional isotopes were collected May 2008 from the lagoons for additional
verification of isotopic evidence. Laboratories analyzed samples as shown in Table 3.
The sample containers were provided by the laboratories in order to ensure that they were
clean, uncontaminated, and suitable for the analysis methods used (Table 4).
The details are further described in the Quality Assurance Plan (QAPP) that is found
in Appendix A and is included within this thesis. The QAPP was based on the EPA
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guideline methods available at the time of the original sampling (EPA 2007a; EPA
2007c). The purpose of the QAPP was to ensure that the sample collection and testing
was performed appropriately. As fieldwork was conducted, the QAPP document was
referenced to maximize the ability of the field sampling team to collect samples reliably
and eliminate sample contamination.

Table 3

Laboratory Analysis Method

Parameters
Caffeine
Carbamazepine
Esterone
Esteradiol
Ethinyl Estradiol
Gemfibrozil
Ibuprofen
Iopromide
Progestrone
Sulfamethoxazole
Testosterone
Trimethoprim

Test Method
USGS 2 mod
USGS 2 mod
USGS 2 mod
USGS 2 mod
USGS 2 mod
USGS 2 mod
USGS 2 mod
USGS 2 mod
USGS 2 mod
USGS 2 mod
USGS 2 mod
USGS 2 mod
IRMS
IRMS

Lab
MWH Laboratories
MWH Laboratories
MWH Laboratories
MWH Laboratories
MWH Laboratories
MWH Laboratories
MWH Laboratories
MWH Laboratories
MWH Laboratories
MWH Laboratories
MWH Laboratories
MWH Laboratories
University of Arizona
University of Arizona

SM 4500-Norg D

Idaho Bureau of Laboratories

Nitrogen, Nitrate+Nitrite
Chloride
Sulfate

SM 4500 NH3 H.
EPA 353.2
EPA 300.0
EPA 300.0

Idaho Bureau of Laboratories
Idaho Bureau of Laboratories
Idaho Bureau of Laboratories
Idaho Bureau of Laboratories

Total Dissolved Solids

SM 2540C

Idaho Bureau of Laboratories

Total Phosphorus

10-115-01-1-F

Idaho Bureau of Laboratories

δ18O%
δD%

Total Kjeldahl Nitrogen,
TKN
Ammonia as N
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Table 4

Sampling Locations and Containers Used
Location

Idaho Bureau of
Laboratories

Well H2O

Monitoring Well 2

2 1-liter
Polyethylene
Cubitainers

Well H2O

Monitoring Well 3

2 1-liter
Polyethylene
Cubitainers

Effluent H2O

WW Lagoon 8

2 1-liter
Polyethylene
Cubitainers

Influent H2O

2 1-liter
Headworks/Lagoon
Polyethylene
1
Cubitainers

Sample

U of Arizona
Environmental
MWH Labs
Isotope
Laboratory
Collect 3
1 125 mL
Samples: 1
Polyethylene
Liter Glass
Container
Amber
Bottles
Collect 3
1 125 mL
Samples: 1
Polyethylene
Liter Glass
Container
Amber
Bottles
Collect 3
1 125 mL
Samples: 1
Polyethylene
Liter Glass
Container
Amber
Bottles
Collect 3
1 125 mL
Samples: 1
Polyethylene
Liter Glass
Container
Amber
Bottles

57

RESULTS AND DISCUSSION
PPCPs were detected in the samples from the headworks, in the storage lagoon
and in a monitoring well downgradient of the lagoon. Twelve PPCPs were tested and
eleven were found in the headworks. Seven PPCPs were found in the storage lagoon. Six
PPCPs were found in downgradient MW 2. Water isotopes from these samples were
examined to further evaluate flow paths.
The sampling results indicate detection of PPCPs in both wastewater and ground
water and a summary of the data from the sampling events are found in Table 5, 6, and 7.
The raw data can be found in Appendix B. The results indicate that PPCPs are present in
detectable and varying concentrations in the samples.
The QAPP defined guidelines for differences within duplicate samples and
allowed concentrations in field blanks. These guidelines, when met, provide a measure of
accuracy, consistency, and validity of the test results. The results were compared with the
QAPP guidelines. Per the QAPP, duplicate samples should be within 30% of each other
in order to be valid. All samples, except Caffeine and Esterone, complied with the
maximum relative standard difference of 30% as specified in the QAPP. Further
discussion of Estrogen related compounds are presented in a section specific to these
compounds. Additionally, the QAPP specifies all field blank samples should contain
below acceptable values for PPCPs. The field blank samples, except Caffeine, were no-
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detect and thus fall within the guidelines specified within the QAPP. As a consequence of
the above analysis, all PPCPs test results, except for those of Caffeine and Esterone, are
considered accurate.
The PPCP data and isotopic data for all samples will now be discussed to provide
a more complete picture of the results. Where connectivity is present between the lagoons
and monitoring wells, PPCP concentrations are evaluated for total removal efficiency.

Table 5

Results for Field Parameters and Major Ions from November 2007
Sampling Event

Major Ions

Field
Parameters

Parameters Units
Temp
pH
Sp Cond
D.O.
turbidity
Ammonia
as N
Cl

PWS
Well
(deg C)
18.6
(units)
8.6
(uS/cm) 401
(mg/L)
NTU

Sample Location
Lagoon
Headworks
MW 2
8
12.5
6.93
1100
0.07
0

14.8
7.24
750
2.67
0

(mg/L)

0.01

19

8.1

(mg/L)

16

33.5

67.8

101

31.70

Nitrogen,
NitrateNitrite

(mg/L)

2.5

0.27

0.58

<0.01

6.00

Nitrogen,
Total
Kjeldahl

(mg/L)

0.2

27

14

0.62

0.30

Total
Nitrogen

(mg/L)

2.7

27.27

14.58

0.63

6.3

(mg/L)

0.02

3.8

4

0.13

0.27

(mg/L)

42

22.7

46.9

19.7

111.0

Total
Phosphorus
Sulfate

0.03

MW 3

0.01
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Parameters Units
Total
Dissolved
Solids

Table 6

Sample Location
Lagoon
Headworks
MW 2
8

PWS
Well

(mg/L)

260

269

516

673

MW 3
523.0

Results for PPCPs from November 2007 Sampling Event
Sample Location

PPCP

Detect
Limit

PWS
Well

Headworks

Lagoon
8

MW2

MW2
duplicate

MW
3

Field
Transfer

Caffeine

5

ND

7920

48

12

36

2.6

ND

Carbamazepine

5

ND

92

64

77

82

ND

ND

Esterone

1

ND

16

450

120

ND

ND

ND

Estradiol

1

ND

ND

49

ND

ND

ND

ND

Ethinyl Estradiol
17 alpha

5

ND

ND

62

9

ND

ND

ND

Gemfibrozil

1

ND

440

880

ND

ND

ND

ND

Ibuprofen

1

ND

1820

ND

ND

ND

ND

ND

Iopromide

5

ND

17

ND

6.8

ND

ND

ND

Progestrone

1

ND

520

ND

ND

ND

ND

ND

Sulfamethoxazole

1

ND

158

87

1.1

5.8

ND

ND

Testosterone

1

ND

ND

ND

ND

ND

ND

ND

Trimethoprim

1

ND

40

ND

ND

ND

ND

ng/L

ND
ND: Non Detect
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Table 7

Isotope Data

Location

Sample Date

δ18O%

δD%

(per mil)

(per mil)

PWS well

Nov-07

-15.5

-124

Headworks

Nov-07

-16.0

-124

Lagoon 8

Nov-07

-7.0

-79

MW-2

Nov-07

-7.6

-83

MW 3

Nov-07

-14.5

-116

Lagoon 7

May-08

-1.5

-56

Lagoon 4

May-08

-8.7

-93

Lagoon 3

May-08

-9.9

-99

Lagoon 2

May-08

-11.3

-106

Lagoon 2

May-08

-11.3

-106

Headworks

May-08

-15.9

-125

Isotopes
Isotope data of oxygen and hydrogen (18O and 2H) are listed in Table 7 and
plotted in Figure 21. The data show an evaporative trend from the headworks through the
series of lagoons.
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Figure 21

Oxygen Versus Deuterium Isotopes for Samples Collected, Plotted
Against the MWL

The headworks and PWS have comparable isotopic values. This confirms that the
water from the regional aquifer has undergone little evaporation as it travels from the
well head through the distribution system and to the wastewater treatment system. The
samples from wastewater treatment lagoons 2, 3, and 4 show a progressive increase in
concentration of the heavier isotopes of oxygen and deuterium. This indicates that the
water in the lagoons has evaporated as it has passed through the successive lagoons as
more 16O and 1H has entered the vapor phase. The storage lagoons contain treated water
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that is entering for storage, and water that has been accumulating in the lagoon for
storage over the winter (or non-irrigation season). The water samples collected from
these lagoons show additional evaporative effects and plot in the upper-right part of the
graph. The range in oxygen and deuterium values reflects evaporative effects of
seasonality and detention time. The storage lagoons are designed so that Lagoon 7 is
filled first and then drawn down last, as water is pumped for irrigation in the summer.
The isotopic evidence also supports this as shown in Figure 21. The results show that the
most evaporation has occurred in Lagoon 7, which has the longer detention time. Lagoon
9 should be the last to fill and the first to empty in the series of three storage lagoons, thus
it will have the shortest detention time for all three storage lagoons. The data confirms
that lagoon 9 has less evaporative effects than lagoon 7 and 8. MW 2 also shows
evaporative effects indicative of surface water from lagoon 9. MW 2 is downgradient of
lagoon 9, and isotope results from the lagoon water and the ground water at MW 2 are
similar. The isotope evidence indicates that ground water at MW 3 does not contain water
that has been exposed to evaporative effects to the same extent as the wastewater
treatment and storage lagoons. This is a line of evidence for establishing that the water
from MW 3 is not hydraulically connected to water seeping from the pond system. These
isotopic data corroborate the ground water flow direction derived from measurement of
ground water level in the perched aquifer (shown in Figure 12) and show that ground
water cannot flow from MW 2 to MW 3. The isotopic results from MW 3 indicate that
ground water at this well is primarily from sources that are not lagoon surface water.
Thus, the ground water flow direction in the perched aquifer is to the west or southwest
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from the lagoons and MW 3 is cross gradient to ground water originating from the lagoon
system. This isotope data is in agreement with conceptual model.

Carbamazepine
Carbamazepine data (Table 8) represented in the column chart shown in Figure 22
indicates that carbamazepine was found in six sampling locations, including MW 2 in the
perched aquifer.
Table 8

Carbamazepine Concentrations from Collected Samples

Analyte

Carbamazepine

PWS

Headworks

Lagoon
8

MW
2

MW 2
duplicate

MW
3

Field
Transfer

ng/L

ng/L

ng/L

ng/L

ng/L

ng/L

ng/L

ND

92

64

77

82

ND

ND

Figure 22 Carbamazepine Concentrations from Collected Samples
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The average concentration found from all six samples taken was 79.2 ng/L. The
carbamazepine concentrations show comparable values (an average of 78 ng/L) through
the wastewater treatment process from the headworks to lagoon eight. The total removal
efficiency of the wastewater treatment system indicates approximately 30% treatment
removal of carbamazepine from the headworks to the storage lagoon. The data from the
samples taken from MW 2 indicate an average concentration of 79.5 ng/L. The isotopes
and the carbamazepine data indicate that the lagoon water is impacting the local perched
aquifer at MW 2. These findings support that carbamazepine shows little attenuation
during ground water recharge. The log [Kow] of carbamazepine (Table 1) is less than 2.5,
which, as discussed earlier, would be predictive of having low sorption potential. This
data supports the premise that carbamazepine sorption is very low. These findings may
also support that carbamazepine can be used as an indicator parameter, to identify and
perhaps quantify domestic waste impact to ground water.
There was no detection of carbamazepine in the blank water field transfer and
MW 3. The carbamazepine data along with the isotope data further suggests that MW 3 is
not downgradient to the lagoon system, and is in agreement with conceptual model.
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Sulfamethoxazole
Sulfamethoxazole data (Table 9) represented in the column chart shown in Figure
23 indicates that sulfamethoxazole was found in the headworks, the storage lagoon, and
MW 2 in the perched aquifer.
Table 9

Sulfamethoxazole Concentrations from Collected Samples

Analyte

Sulfamethoxazole

PWS

Headworks

Lagoon
8

MW
2

MW 2
MW Field
duplicate
3
Transfer

ng/L

ng/L

ng/L

ng/L

ng/L

ng/L

ng/L

ND

158

87

1.1

5.8

ND

ND

Figure 23 Sulfamethoxazole Concentrations from Collected Samples
Sulfamethoxazole shows a decreasing concentration from process order in the
wastewater treatment lagoons. The trend in concentration from the headworks to the
storage lagoon indicates attenuation during treatment, and then further attenuation from
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the lagoons to MW 2. Utilizing the supporting evidence that MW 2 is connected to the
lagoons based on the information referenced in Figure 21, the sulfamethoxazole data
indicates that sulfamethoxazole attenuation occurs from the storage lagoon during
transport to MW 2. There was no detection of sulfamethoxazole in the blank water field
transfer or in samples from MW 3. The carbamazepine and sulfamethoxazole data along
with the isotope data further suggests that MW 3 is not downgradient to the lagoon
system and is in agreement with the conceptual model. Sulfa drug removal, as discussed
earlier, is shown to be variable and detectable in effluent and this data supports that
incomplete removal is occurring. Only about 15-20% of the active drug appears in the
urine and this population base of 11,000 provides enough sulfamethoxazole to be
detected in the headworks. These data also suggest, approximately 55% total removal
efficiency from the headworks to the storage lagoons.
These data show low dose concentrations of the antibiotic sulfamethoxazole in the
storage lagoon. As discussed earlier, there is concern over low dose antibiotics in
wastewater lagoons and the potential for the spread and maintenance of multi-resistance
bacterial pathogens.
Sulfamethoxazole is seeping from the lagoons into the perched aquifer in very
small but detectable concentrations that average 3.5 ng/L.
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Gemfibrozil
Gemfibrozil data (Table 10) represented in the column chart shown in Figure 24
indicates that gemfibrozil was found in the headworks and the storage lagoon but not in
the perched aquifer.
Table 10

Gemfibrozil Concentrations from Collected Samples

Analyte
Gemfibrozil

PWS Headworks

Lagoon MW MW 2
MW Field
8
2
duplicate
3
Transfer

ng/L

ng/L

ng/L

ng/L ng/L

ng/L ng/L

ND

440

880

ND

ND

ND

ND

Figure 24 Gemfibrozil Concentrations from Collected Samples
Gemfibrozil is found in treated effluent from various wastewater treatment
systems and these data show an increasing concentration trend from process order in the
wastewater treatment lagoons from the headworks to the storage lagoon. Since
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gemfibrozil is excreted as a metabolite, which was not tested for in this study, the
increased concentration can plausibly be explained by transformation of metabolites to
gemfibrozil in the storage lagoons. Additionally, evaporative effects within the storage
lagoons may lead to increased concentration of gemfibrozil. Analysis of total removal
efficiency does not apply, as the data shows an apparent increase in concentration during
the lagoon treatment process. Gemfibrozil has a high hydrophobicity (Table 1) with a log
[Kow] of 4.77 and its preference to partition to sludge could be explained by this data.
There was no detection of gemfibrozil in the blank or monitoring wells.

Estrogens
There were four estrogens analyzed in the sampling and the data (Table 11) is
shown in the column chart in Figure 25.
Table 11

Estrogen Concentrations from Collected Samples
PWS

Headworks

Lagoon MW MW 2
MW Field
8
2
duplicate
3
Transfer

ng/L

ng/L

ng/L

ng/L ng/L

ng/L ng/L

Esterone

ND

16

450

120

ND

ND

ND

Estradiol
Ethinyl
Estradiol 17
alpha
Progestrone

ND

ND

49

ND

ND

ND

ND

ND

ND

62

9

ND

ND

ND

ND

520

ND

ND

ND

ND

ND

Analyte
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Figure 25 Estrogen Concentrations for Collected Samples
There was no clear overall trend with the estrogens. Esterone, Estradiol, and
Ethinyl Estradiol 17alpha show increased concentrations in the storage lagoon. These
data are indicative of Esterone, Estradiol, and Ethinyl Estradiol 17alpha undergoing deconjugation of the metabolite during treatment, thus forming the parent compound. There
was no analysis for estrogen metabolites, as a consequence a non-detect in the headworks
of the parent compound (the estrogen), followed by a subsequent detection in the
treatment process, can indicate that metabolites exist. Estimation of a total removal
efficiency of this system for estrogens is not possible without the metabolite data.
Progesterone was only found in the headworks of the treatment system and was not
detected in other samples, which may indicate treatment in that it either breaks down or is
partitioning to the sludge during treatment. The log [Kow] of 3.67 (Table 1) predicts a
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medium to high sorption potential and thus partitioning to the sludge during treatment is
likely. The sampling data from MW 2 detected only two estrogens, Esterone and
Estradiol. There were inconsistencies in concentrations analyzed for estrogens in MW 2.
There is no known explanation for this. The sludge or alluvial materials were not studied
to determine if estrogens are preferentially partitioning to sludge or breaking down.

Total Nitrogen
The wastewater treatment system is designed for nitrogen removal and the data
(Table 12) as shown in the column chart in Figure 26 indicates that nitrogen removal is
occurring from the headworks to the storage lagoon.
Table 12

Total Nitrogen from Collected Samples

Analyte
Total Nitrogen

PWS

Headworks

Lagoon
8

MW
2

MW
3

mg/L

mg/L

mg/L

mg/L mg/L

mg/L

2.7

27.27

14.58

0.63

ND

6.3

Field
Transfer
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Figure 26 Total Nitrogen from Samples Collected
Ground water at MW 2 has a very low total nitrogen concentration. A significant
decrease in total nitrogen occurs in the vadose zone as seepage moves from the storage
lagoon to the perched aquifer. At this site, there is an unknown mechanism by which
nitrogen is being removed from the ground water going to this well. By comparison,
ground water at MW 3 has a much higher total nitrogen concentration, which indicates
that the attenuation is not the same mechanism. This supports previous discussed trends
with isotope and PPCP data, which support that MW 3 is not connected to the lagoons,
that ground water flow is to the west or southwest from the lagoons, and is in agreement
with the conceptual model. The source of nitrogen must originate from areas to the east
or northeast.
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CONCLUSION
This study confirmed that during the course of wastewater treatment in a lagoon
system PPCPs from a small population base are present in inflow to a lagoon treatment
system and also within the treatment and storage lagoons. Through development of a
conceptual model and isotope sampling data the study provided evidence of hydraulic
connectivity between the lagoons and a downgradient ground water monitoring well.
Furthermore, some PPCPs were shown to have traveled from the lagoons to a
downgradient ground water site, which is in agreement with the conceptual model. The
study also suggests that PPCPs may exist as metabolites within the headworks and
subsequently reform to the biologically active parent compound at later stages of
treatment and in downgradient ground water. This is a critical point when studying
compounds such as estrogens, since the metabolites must also be studied in order to form
a quantitatively accurate study. The transformations of PPCPs makes studying and
quantifying the PPCPs and their metabolites in a treatment system more complicated. The
metabolites and their properties may allow for additional environmental pathways of
transformation. This study did not include metabolites and, as a consequence, limited the
ability of the study to characterize PPCPs, where metabolites may be present. The PPCP
detections at this site can help define exposure and add to the data for development of
models for predicted environmental concentrations and risk assessment. Where
background environmental levels of biologically active PPCPs exist, the impacts from
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chronic low dose exposure are relatively unknown in living organisms. Exposure data
and toxicity data are important pieces of understanding for developing risk and must
include the effects from a specific PPCP and concomitant exposure. Another area for
further study is the unintentional exposure of non-target species of PPCPs developed for
human health benefit and the environmental cascading effects that may occur from those
affected species.
This Idaho study of PPCPs in a municipal wastewater treatment lagoon system
could be expanded. Further studies could be directed in two broad categories. The first
category could be those studies that concern the specific environment that the PPCPs are
traveling within and the second category would be the study of the PPCPs within those
travel pathways.
Within the first category, the hydrogeology of the study area could be mapped in
greater detail to further refine the model of potentiometric ground water flow. This could
be done through the drilling of additional monitoring wells and subsequent monitoring of
ground water levels. Additional well data could be used to further characterize the vadose
zone and geologic formations at the study site. Another potential area of study would be
to examine the plume characteristics within the ground water. This could be
accomplished by increasing the number of sampling sites. Studies within this category
would also substantiate the assumptions about the subsurface conditions below the
lagoons and the ground water flow patterns at this site.
The second category of studies could include a longitudinal study and quantitative
analysis of PPCPs and related metabolites in the various stages of treatment along with
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dye tracer studies to determine the actual mixing that occurs in each lagoon. The lagoon
sludge could be analyzed for PPCPs to further define the assumptions with hydrophobic
PPCPs and partitioning to the sludge. The study of this sludge and its life cycle could
provide important information about PPCP fate and transport. Sludge is often removed
from lagoons and land applied and there is limited research in this area of study to date.
The list of PPCPs studied could also be expanded. The regional aquifer downgradient
from this site could be explored for impacts from PPCPs and other parameters. The
vadose zone below the lagoons could be defined and core samples taken and analyzed for
PPCPs.
Additionally, in this second category of study, the liquid and solid streams of
exposure could be evaluated based upon their use as nutrients for crops, and assimilation
of PPCPs within those crops before and after crop harvest and processing. Human
wastewater has nutrients that become more valuable as land resources become limited
and agricultural needs grow with the growing world populations. The understanding of
risk from the liquid and solid streams generated from wastewater treatment is important
to global sustainability as it applies to wastewater reuse. With wastewater reuse, the
needs for fresh water sources and ground water recharge must be considered.
As PPCPs primarily enter into wastewater treatment systems through the sewers,
reducing the probability of exposure may be an important function of the mitigation
efforts that should be explored. Concerned communities can immediately attempt to
reduce loading to sewer systems of PPCPs through community drug take back programs.
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Studies that begin to identify and quantify the reduced loadings of PPCPs in the sewer
would be another avenue for exploration in mitigation.
This study found PPCPs contributed to the environment through municipal
wastewater lagoon treatment, which adds to the exposure data and supports that further
study of PPCPs is imperative and of concern.
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Project Description and Objectives
This study involves sampling for a selected set of Pharmaceuticals and Personal
Care Products (PPCP’s) in wastewater before and after treatment, and from existing wells
in the vicinity of a wastewater treatment and land application site. Limited information
now exists on the fate of these chemicals in soils and groundwater and this project
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provides a contribution specifically for the state of Idaho that investigates groundwater
impacts from municipal wastewater sources. Groundwater monitoring from this
wastewater treatment and land application site will be a reconnaissance mission to answer
the following questions: Are any of the set of PPCPs present? What concentration are
they present in? Where were they found?

Purpose of This Study
The purpose of this study is to investigate a municipal wastewater land
application site in Idaho to evaluate contributions of Pharmaceuticals and Personal Care
Products to groundwater from treated water. The multiple samples from the path of the
waste water stream will be analyzed for fifteen PPCP’s. These sample data will be used
to further characterize the fate of the selected set of PPCP’s from municipal waste water
effluent. Limited information exists on the fate of these PPCP’s in soils and groundwater
and this project would provide a contribution specifically for the state of Idaho that
investigate impacts of PPCP’s from municipal wastewater sources.

Site Criteria
Sites considered were within the state of Idaho. A site that has a history of
municipal wastewater application and soils and monitoring well sample results is ideal. A
site that has a significant population base, enough to provide a diverse pharmaceutical
and personal contaminant load to a treatment system would also be ideal.

2

Wastewater Treatment Methods
Secondary or tertiary treatment with land application is preferred and lagoons are
a common treatment system used prior to land application. There are over 7000
facultative lagoons that serve communities around the United States and a site with
facultative lagoons may provide information about fate and transport with this treatment
method.

Potential Sites Evaluation
The City of Mountain Home located in Elmore County Idaho may be a good site.
The City treats municipal waste water in a series of facultative treatment lagoons and
land applies the treated wastewater to approximately 260 acres of farm ground. There are
two dedicated monitoring wells down gradient of the treatment lagoons. The site has been
permitted for land application since 1989.
The City of Kuna, New Meadows and Calloway Ranch were considered as
potential sites. The population base and location of groundwater wells make the City of
Mountain Home site a better choice over these three other sites.

Site Identification
The City of Mountain Home sits on a southwest sloping broad flat plateau 3140
feet above mean sea level. The city has a population of about 11,200 people and treats
municipal wastewater through lagoon treatment followed by chlorine disinfection and
then slow rate land application during the growing season (April 1 through October 31).
The site is approximately 2.5 miles south of the city. Eight facultative lagoons with a
total volume of 284 million gallons) and an 84 million gallon storage lagoon (s) collect
3

and treat the wastewater from the city. The wastewater application area is comprised of
five management units (MU). Irrigation pumps apply effluent in accordance with crop
needs to these fields which are planted with small grain, alfalfa and sugar beets.
Chlorination automatically runs when the pumps are in operation. Effluent flows from the
storage lagoon and a chlorine solution is injected through an across the pipe diffuser. It
then travels about .5 mile to the irrigation pump station. The chlorine contact time is
provided in this travel time. The number of irrigation lines in use at any particular time
varies based on crop needs and acreage. Disinfected lagoon effluent is applied to a 258
acre land application area.
There are a variety of loam soils on site with varying depths. Depth to ground
water in the deep regional aquifer is from 200 to 400 feet below land surface. There is
also a localized perched aquifer in the vicinity of the treatment lagoons that has a depth to
groundwater of 2 to 40 feet below land surface. This perched aquifer occupies about
38,000 acres and is found mainly in the clay, silt, sand and gravel of the Quaternary
Alluvium. The beneficial uses of groundwater in the area are for drinking and agricultural
irrigation. Recharge to the regional aquifer occurs through precipitation in the mountains
north of Mountain Home, percolation from ephemeral streams on the plateau and through
percolation from the perched aquifer. The regional aquifer has permeable zones of highly
fractured basalt that occur within dense, relatively impermeable flow units. Groundwater
flow in the regional aquifer is generally in a south to southwest direction. Recharge to the
perched aquifer occurs from local creeks, irrigation canals and the nearby reservoir.
Seepage from the wastewater treatment lagoons also provides some recharge to the
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perched aquifer. The direction of ground water movement in the perched aquifer at the
wastewater treatment site is believed to be to the southwest.

Project/Task Description
The purpose of this project is to gain a better understanding of PPCP contaminant
contributions from wastewater to groundwater. This monitoring will focus on the water
quality sampling of existing ground water wells and nearby sewer lagoons to further
characterize impacts by a selected set of PPCPs. Water Samples will be collected over
two phases. Phase one will involve taking water samples at four locations to serve as
assessments for contributing concentrations of 15 PPCP’s. Phase two will be determined
after the results have been assessed for phase one. Phase two will involve sampling
existing area wells based upon well location, well depth and permission from landowners.
Specific testing and objectives for both phase one and two are as follows:
•

Onsite field parameters measurements will be evaluated at all water collection
sites to characterize water properties and evaluate purging effectiveness. Field
parameters for specific conductance, pH, temperature, and total dissolved solids
will be measured.

•

Cations and anions will be tested from water samples collected at all monitoring
sites to evaluate water chemistry to determine variations of potential source water
and contaminants in the area.

•

Nitrate testing will be completed for all collections sites to determined extent and
boundaries of nitrate contamination.

•

PPCP sampling for 15 specific analytes will be conducted to determine potential
influence of wastewater streams contribution of PPCP’s to the environment.
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•

Stable isotope testing samples will be collected and archived for each ground
water collection site. This testing may provide additional information to delineate
nitrate sources, ground water recharge sources, and variations in isotopic
chemistry across the area.

Quality Objectives and Criteria for Measurement Data
The objectives of quality assurance and quality control (QA/QC) is to assure that
analytical results obtained by sample analyses are representative of actual chemical and
physical compositions of the water samples in the field. Project management will be
responsible for QA/QC associated with collection of samples, this includes a duplicate
and field blank for the first four samples taken in phase one. The duplicate will consist of
sample containers filled with the same composite water from the same sampling site. The
duplicates will be used to determine both field and laboratory precision. The field blank
sample is used to determine the integrity of the field sampling events, the condition of the
sample containers supplied by the laboratory and the accuracy of the laboratory methods.
Both the duplicates and blank samples are stored and handled with the normal sample
load for shipment to the laboratory. Laboratory duplicate samples should be within 30%
of each other. Blank samples should contain below their acceptable values of PPCPs.
Phase two details for this project are yet to be determined, and the data from
phase one will be used for decisions on further sampling.
Project management will provide assurance that the selected analytical
laboratories will use appropriate QA/QC methods. A laboratory that has met the
Unregulated Contaminant Monitoring Regulations (UCMR) Laboratory Approval
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Program application and Proficiency Testing (PT) criteria will be used for assessment of
PPCP’s. The laboratory will be approved for UCMR 2 and can only use EPA Approved
laboratory for sampling UCMR using EPA 527, 529, 521, 525.2 and 535 methods for
PPCP analysis. MWH Laboratories will be used for PPCP sample testing as it has met the
above requirements.
The laboratory used for testing of general field parameters is the Idaho Bureau of
Laboratories which is certified for the chemical and microbiological testing of drinking
water from public water systems as part of the primacy agreement between the State of
Idaho and EPA. It is certified for microbiological, organic chemistry and inorganic
chemistry analytes and methods.
The laboratory used for isotopes will be the U of Arizona Environmental Isotope
Laboratory. This laboratory has been used for isotope testing previously for some of the
sample sites and will be used for consistency.

Special Training Needs/Certification
All personnel on the water sampling team will review procedures for using EPA
Method 1669 (i.e., “clean hands/dirty hands” procedures) for Sampling Ambient Water
for Trace Metals. This protocol will be modified for sampling trace PPCP’s with
appropriate considerations for the ability to contaminant water samples with the PPCP’s
of interest. The intent is to maximize the ability of the field sampling team to collect
samples reliably and eliminate sample contamination.
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Documents and Records
Documentation for this project will include historical data kept on file at DEQ’s
state office, as well as all documents created for the sampling events addressed under this
QAPP. The generated documentation will consist of at least those documents developed
for sample collection procedures, a report summarizing the sampling events and results,
and this QAPP. Field notebooks and field data sheets will also be kept and included in the
project file. This information will be available and reviewed by the project management
for quality control purposes. The data will be recorded using these procedures:
•

Project data must be recorded directly, promptly, and legibly.

•

Field logbook entries must be made in black or blue permanent ink and must be
initialed and dated by the person making the entry.

•

Changes or corrections to data must be indicated with a single line through the
original entry.

A dedicated field logbook will be used to document the following information
during each sampling event:
•

Purpose of sample event;

•

Make and model of all equipment used;

•

Name of sampling personnel and/or field crew;

•

Identification of the sampling site (e.g., GPS coordinates, benchmark location,
etc.);

•

Weather conditions and time of arrival at site;

•

Brief description of site conditions, and sampling setup;

•

Date and time of sample collection;
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•

Sample identification numbers and parameters requested;

•

Field parameter measurements and methods;

•

All relevant observations pertaining to each sampling event.
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DATA GENERATION AND ACQUISITION

Sampling Process Design (Experimental Design)

Site and Sampling Procedure
The wastewater treatment area for the City of Mountain home was chosen for
Phase One. Four sampling locations were chosen to be sampled in series from the site
that is assumed to have the least potential of PPCPs to the site that may have the greatest
potential for highest concentration of PPCPs. Samples will also be taken from Monitoring
Well 2 then Monitoring Well 3. Afterward, grab samples of wastewater will be collected
from the last wastewater lagoon in series and then near the head-works or influent to the
first lagoon. Based on the data collected from phase one of sampling, additional locations
for sampling will be proposed for phase two, and future revisions to this QAPP.
At each location, field parameters for specific conductance, pH, temperature, and
total dissolved solids will be measured. The pH and conductivity meters will be
calibrated to manufacturer specifications, then measurements will be taken from each
well while purging. Field parameter measurements will be considered stable when three
successive measurements taken at intervals of 5 minutes or more differ by the following:
10

specific conductance 5% or less, pH 0.1 unit or less and temperature 0.2 ºC or less, after
which three sets of samples will be taken to be sent to three different laboratories for each
sampling site.

TABLE 1. LABORATORIES
Laboratory List

Parameters

Address

Idaho Bureau of
Laboratories

TKN, NH4, NO3-N, Cl,
SO4, TDS, Total P

2220 Old Penitentiary Rd
Boise ID 83712

U of Arizona
Environmental Isotope
Laboratory

Isotopes: 18O, D, 15N

Dept. of Geosciences
Tucson, AZ 852721-0077

MWH Laboratories

PPCP's

750 Royal Oaks Dr, Ste
100, Monrovia, CA
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TABLE 2. SAMPLING CONTAINERS
U of Arizona
Environmenta
l Isotope
Laboratory

MWH Labs

Sample

Location

Idaho Bureau
of
Laboratories

Well H2O

Monitoring
Well #2

2 1literPolyethyle
ne cubitainers

1 125 mL
polyethylene
Container

Collect 3
Samples: 1
Liter each

Well H2O

Monitoring
Well #3

2 1-liter
Polyethylene
cubitainers

1 125 mL
polyethylene
Container

Collect 3
Samples: 1
Liter each

Effluent H2O

WW Lagoon 8

2 1-liter
Polyethylene
cubitainers

1 125 mL
polyethylene
Container

Collect 3
Samples: 1
Liter each

Influent H2O

Headworks/La
goon 1

2 1-liter
Polyethylene
cubitainers

1 125 mL
polyethylene
Container

Collect 3
Samples: 1
Liter each

Sampling Methods
The sample procedures described below are designed to very conservatively
minimize the potential for contamination of the samples. The procedures may be changed
based on field experiences and future discussions, and minor deviations from these
procedures will not necessarily invalidate the samples but should be noted within the
field logbook.
All field personnel must be extremely conscientious with respect to field and
sampling techniques while involved with or around collection of samples. Constant care
and consideration must be exercised to avoid any contamination of the sampling sites or
sample containers. Prior to donning personal protective equipment (PPE) and/or
obtaining any sample, field personnel should designate various roles and responsibilities
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for each member of the sampling team and discuss procedures to be utilized during
sampling events. Care should be taken not to spill any contaminants (e.g., water, etc.) on
or near the sampling site, or to let any sampling equipment come into contact with the
potential contaminants.
Field personnel will wear powder-less nitrile laboratory gloves during sampling
and processing. They will change to clean gloves with each change in activity or potential
glove contamination. They will avoid breathing directly over open samples/equipment.
They will avoid direct contact between themselves (including clothing) and the sample,
sampling device, and processing equipment. Field personnel have been briefed that
clothing is a source of detergents, fragrances, and fire retardants. On the day of sampling
activities, they will avoid contact with or consumption of the products listed below:
•

Wastewater compounds such as soaps and detergents, including antibacterial
cleansers. The laboratory analysis of wastewater includes triclosan, an active
ingredient in most antibacterial soaps. Triclosan is also commonly found in some
deodorants, toothpastes, mouthwashes, skin creams, lotions, laundry detergents,
and dish soaps.

•

Pharmaceutical compounds such as prescription drugs, medications, and
hormonal substances that are in the list of PPCP’s.

Upon arrival at the sampling sites one member of the two person sampling team is
designated as “dirty hands” and the other “clean hands.” The personnel assuming the
“dirty hands” and “clean hands” roles will don Tyvek coveralls and powderless nitrile
laboratory gloves, and surgical masks with sampling equipment and containers
appropriately staged nearby. The dirty hands sampler will observe techniques employed
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by clean hands personnel and should notify the field team immediately in the event that
any possible contamination is observed or suspected, or if incorrect sampling techniques
are utilized.
The clean hands sampler will touch the sample container and transfer the sample
from the sample collection device to the sample container. The dirty hands sampler will
be responsible for the operation of the machinery and all other activities that do not
involve direct contact with the sample. “Clean hands” places the clean empty sample
containers, removes the lids of the containers and places the end of the tubing into the
containers. “Dirty hands” starts the pump. “Clean hands” moves the tubing to a clean
container. “Dirty hands” stops the pump. “Clean hands” replaces the lid on the container
and returns the container to the designated place. “Dirty hands” places the bottle into the
cooler. Gloves are changed between samples and sample sites. After each sample is
collected, the sample number is documented in the field log along with observations by
“Dirty hands”.
Samples should be collected as quickly as is reasonably possible, while carefully
preventing any contact between the containers and any surface other than the sampling
surface. Lagoon samples are collected by using a grab sampling technique, through
immersion into the water by a certified clean amber glass bottle and transferring that into
the laboratory prepared bottles. The monitoring well samples will be collected using a
peristaltic pump. The water will be pumped to the surface and the sample containers
filled directly. Care will be taken to avoid breathing over the sample containers and
masks will be worn. If any contamination of the sample container occurs or is suspected
prior to, during, or after sampling, the container in question should not be used in the
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sampling event, and will be replaced with a new, uncontaminated sample container. Care
will be taken to avoid contaminating the equipment on site.
Collected samples will be stored in ice chests with freezer packs to maintain 4oC
from the time of the sampling event until sample custody is transferred to the lab. MWH
labs will provide ice chests designated for their samples. DEQ ice chests with ice will be
used for samples designated for Idaho Bureau of Laboratories and U of Arizona
Environmental Isotope Laboratory. After leaving the field, samples going to MWH
laboratory will be packed for shipment and sealed in ice chests with refrigerated packs,
with the required chain of custody forms. Samples going to Idaho Bureau of Laboratories
will be dropped off by field personnel and samples going to U of Arizona Environmental
Isotope Laboratory will be shipped.

Sample Handling and Custody
Samples will be directly transported to DEQ headquarters in Boise in coolers with
cold packs that were previously frozen. These coolers will be shipped overnight to MWH
Laboratories. All proper chain of custody forms will accompany samples throughout the
duration of the shipping process.
After the samples have been collected, they will be placed in an ice chest on
freezer packs, and held under chain of custody until they are hand delivered to the
shipping agent. A chain of custody form will accompany each shipment during transport
to the lab. Each ice chest will be sealed just prior to release of custody, with a completed
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and properly signed chain of custody form affixed to the inside of the ice chest. The chain
of custody form will include the following information:
•

Project name/code;

•

Client’s name and address;

•

Laboratory name and address;

•

Sample identification number;

•

Date and time of collection;

•

Type of sample, number of containers, and analysis requested;

•

Sample preservation methods;

•

Field information and remarks;

•

Sample location;

•

Calibration information and procedures;

•

Signature of sample collector(s);

•

Inclusive dates of possession.

The following procedures will be followed to ensure proper chain of custody:
•

The sample and seal information checked to verify that they match the chain of
custody form;

•

The chain of custody record will be checked for a signature;

•

A laboratory sample number will be assigned;

•

The sample will be stored in a secure area until it is analyzed.
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Analytical Methods
Three different laboratories will be used to analyze the samples. See the following
tables:

TABLE 3. MWH LABORATORIES PPCP PARAMETERS AND ACCURACY
Analytes

Description

Detection Limit
(ng/L)

Test Method

Caffeine

CNS stimulant

1

USGS 2 mod

Carbamazepine

anticonvulsant

5

USGS 2 mod

Esterone

steroid

1

USGS 2 mod

Esteradiol

steroid

1

USGS 2 mod

Ethinyl Estradiol

steroid

5

USGS 2 mod

Gemfibrozil

HDL drug

1

USGS 2 mod

Ibuprofen

nonsteriod anti
inflammatory

1

USGS 2 mod

Iopromide

contrast agent

5

USGS 2 mod

Progestrone

steriod

1

USGS 2 mod

Sulfamethoxazole

antibiotic

1

USGS 2 mod

Testosterone

steroid

1

USGS 2 mod

Trimethoprim

bacteriostatic
antibiotic

1

USGS 2 mod
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TABLE 4. U OF ARIZONA ENVIRONMENTAL ISOTOPE LABORATORY
Analytes

Method

18

O

Isotope Ratio Mass Spectrometry (IRMS)

D

Isotope Ratio Mass Spectrometry (IRMS)

N

Isotope Ratio Mass Spectrometry (IRMS)
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TABLE 5. IDAHO BUREAU OF LABORATORIES
Analytes

Method

Total Kjeldahl Nitrogen, TKN

SM 4500-Norg D

Ammonia as N

SM 4500 NH3 H.

Nitrogen, Nitrate+Nitrite

EPA 353.2

Chloride

EPA 300.0

Sulfate

EPA 300.0

Total Dissolved Solids

SM 2540C

Total Phosphorus

10-115-01-1-F

Quality Control
Quality control checks include internal checks for sampling analysis activities,
duplicate samples and field blanks. Quality Control procedures for the laboratories have
been certified through the US EPA. The following list documents key components of the
QA/QC program for this project.
•

Laboratory: The PPCP analytical laboratory will provide appropriate samples
containers, chain of custody forms, sample labels, and any necessary container
seals. A laboratory QA/QC report with continuing calibration checks will
accompany each data report and will be stored in the DEQ state office. DEQ will
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provide the sample containers that are approved for use in the other two
laboratories.
•

Sample Collection: All QA/QC procedures for sample collection will be followed
by sampling personnel. For this sampling project, the QA/QC procedures will be
fulfilled by adhering to all requirements of Section 2 and such adherence will be
demonstrated through appropriate documentation of sampling procedures within
the field logbook. A standard field logbook, dedicated solely for use in this
project, will be kept for all sampling events and will follow the format described
in Section 2.

•

Field Duplicates: A duplicate sample will be collected and prepared at one of the
four sampling sites. All relevant information will be recorded for the duplicates in
the field logbook. The duplicates will allow assessment of repeatability and
accuracy of the sampling procedures and will also be used to assist in assessment
of any cross-contamination issues. Results from the field duplicate analysis will
be presented in the analytical report.

•

Field Blank: The purpose of the field blank is to assess the amount, if any, of the
analytes as contaminants that could be collected in sample containers while open
and exposed during sample collection procedures. The field blank will be
prepared with a standard supplied by MWH laboratories and shipped from the lab
with other sample bottles. The field blank will be sent for analysis with other
samples collected for analysis, and results of the field blank analysis will be
included in the analytical report.

Personnel will conduct a field blank procedure at one site, during collection of a
sample. The same procedures and clean hands/dirty hands techniques used for sample
collection will generally be observed in handling and preparing the field blank. It is
critical that the field blank container be isolated from contact with any surfaces or other
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possible sources of contamination that would have been isolated from contact or exposure
to the sample containers.
The clean hands sampler will carefully accept an empty sample container,
designated as the field blank container, from the dirty hands sampler, and will then open
and place the container in an appropriate location determined by field personnel. The
actual location to be used will be determined in the field, based on actual site parameters
and conditions. The field blank container will be maintained in the vicinity of the
composite sample collection location, but must be isolated from any situation or location
that might reasonably be expected to skew or invalidate the purpose of the field blank.
The clean hands sampler will fill the field blank container with 1 L of standard water
supplied by MWH Labs prior to collection of the well sample for analysis. The well
sample procedure will then be conducted per required techniques, exercising care to
avoid any unnecessary actions that may cause interference with the field blank
assessment. The field blank container will be kept open throughout the sample collection
procedure. After the sample has been collected and the container closed, the clean hands
sampler will seal and then relinquish the field blank container to the dirty hands sampler.
The identification number of field blank container shall be recorded in the field logbook,
along with all other required sample information.

Instrument/Equipment Testing, Inspection, and Maintenance
Procedures and schedules for preventive maintenance of sampling equipment are
the responsibility of project management. Each instrument or item of laboratory
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equipment will be maintained periodically to ensure accuracy. These procedures and
frequency of performance are designated in the individual instrument manuals.

TABLE 6. EQUIPMENT TESTING, INSPECTION, AND MAINTENANCE
REQUIREMENTS
Equipment Type

Inspection Frequency

Type of Inspection

Field parameter meters

Daily when in use

Physical measurement of
standardized solution prior
to use in the field.

Tyvek suits, surgical masks
and nitrile gloves

Daily when in use

Visual for cuts, tears, etc.

Daily when is use

Visual of PPCP Amber
bottles that they are sealed
and appear clean.
Visual for other parameters
that they appear clean.

Sample Bottles

Instrument/Equipment Calibration and Frequency
Each instrument or piece of equipment will be calibrated and maintained to ensure
accuracy within specified limits. The calibration of analysis instrumentation used under
this project will be the responsibility of the technical personnel assigned to the project.
The equipment used to collect samples will be calibrated according to manufacturers'
procedures or internal guidelines at recommended intervals. Calibration sheets that
contain the calibration procedures and the results of each calibration, or the equivalent,
will be kept on file. The calibration sheets will also serve as a permanent record of
maintenance for the sampling equipment.
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TABLE 7. EQUIPMENT CALIBRATION REQUIREMENTS
Equipment Type

Calibration Frequency

Standard or Calibration
Instrument Used

Field parameter meter

Prior to sampling round

Standardized calibration
fluid

Inspection/Acceptance of Supplies and Consumables
Sample containers, labels and associated preservatives will be provided by MWH
laboratories. Instructions provided by MWH laboratories will be followed throughout the
duration of the project.

Data Management
The sampling team is responsible for collection, storage, and transport of field
data to the office. A standard system for sample labeling and correlation with appropriate
field notes and QC checks will be developed. Laboratory and field data will be compiled
by project management.
Hard copies of all field notes and field data sheets will be kept on record at the
DEQ office. All information pertaining to this project will be stored in the source files,
and electronic copies of all reports will be available for review upon request.
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ASSESSMENT AND OVERSIGHT

Assessments and Response Actions
The purpose of assessment is to ensure that this plan is implemented as
prescribed.
The quality director will have the lead role in assessing the QA and QC measures
employed in this study (e.g. review of sampling procedures). The two project mangers
will work together to determine appropriate QA and QC measures. They will also have
the lead role in data quality review. Both will work together to assure overall project
objectives are met.
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Reports to Management
The final field report will be prepared by the project manager and will include:
•

A summary of the field work conducted

•

The results of the laboratory analyses, including quality assurance measures

•

A QA and QC summary

•

Conclusions

No specific action will be required by any recipient of the report.
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DATA VALIDATION AND USABILITY

Data Review, Verification, and Validation
The objectives of this project are to provide information to determine if any of the
set of PPCPs present is present in the wastewater and groundwater at this site? What
concentration are they present in? Where were they found? This important information
for validation concerns the sampling methods. Verification requirements concern the
quality of the actual data and interpretation of the data. Compliance with sampling
protocol, record keeping, labeling as defined in this document constitute the requirements
for verification.

Verification and Validation Methods
The project managers will be responsible for reviewing the project, collecting
samples, labeling, storage, transport, sending the samples for analysis and summarizing
the data. They will confirm that the data generated complied with the specifications fo the
procedures and objectives of the proposal. Any deviations will be noted and whether to
reject, accept or qualify the data will be determined. Data will be subject to visual
25

inspection and any questions as to values or sample identity will be resolved via line-byline confirmation with the analyzing laboratory.

Reconciliation with User Requirements
Data and conclusions will be peer reviewed at both at DEQ and Boise State
University. The peer-review process is set up to identify technical and scientific concerns.
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Project Data
Monitoring for Pharmaceuticals and Personal Care Products
from a Wastewater Treatment Site
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REPORT OF ANALYSES

4 water samples for N, O and H isotopes

Sample ID
1 (MW-3)
2 (MW-2)
4 (Lagoon 8)
5 (Headworks)

W

δ18O ‰

δD ‰

δ15N ‰

36140
36141
36142
36143

-14.5
-7.6
-7.0
-16.0

-116
-83
-79
-124

14.6
7.8
10.6
0.9

0.08

0.9

0.15

Analytical Precision (1-sigma)

C.J.Eastoe
Staff Scientist

